{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:40:29Z","timestamp":1709869229044},"reference-count":317,"publisher":"Oxford University Press (OUP)","issue":"813","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1993,7,1]]},"DOI":"10.1136\/pgmj.69.813.516","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:25:21Z","timestamp":1230585921000},"page":"516-546","source":"Crossref","is-referenced-by-count":0,"title":["Nephrology, dialysis and transplantation"],"prefix":"10.1093","volume":"69","author":[{"given":"K","family":"Farrington","sequence":"first","affiliation":[{"name":"Lister Hospital , Stevenage"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Sweny","sequence":"additional","affiliation":[{"name":"Royal Free Hospital , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1993,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(79)92191-3","article-title":"Hematuria: glomerular or non glomerular?","volume":"ii:","author":"Birch, D.F.; Fairley, K.F.","year":"1979","unstructured":"Birch, D.F. & Fairley, K.F. Hematuria: glomerular or non glomerular? Lancet 1979, ii: 845-846.","journal-title":"Lancet"},{"key":"ref_2","first-page":"337","article-title":"Microscopic examination of the urinary sediment to differentiate high from low renal bleeding","volume-title":"International Yearbook of Nephrology","author":"Schumann, G.B.; Schumann, J.L.","year":"1992","unstructured":"Schumann, G.B. & Schumann, J.L. Microscopic examination of the urinary sediment to differentiate high from low renal bleeding. In: Andreucci, V.E. & Fine, L.G. (eds). International Yearbook of Nephrology. Springer Verlag, London, 1992, pp. 337-352."},{"issue":"2","key":"ref_3","first-page":"84","article-title":"A new morphological classification of urinary erythrocytes for differential diagnosis of glomerular haematuria","volume":"37","author":"Tomita, M.; Kitamoto, Y.; Nakayama, M.; Sato, T.","year":"1992","unstructured":"Tomita, M., Kitamoto, Y., Nakayama, M. & Sato, T. A new morphological classification of urinary erythrocytes for differential diagnosis of glomerular haematuria. Clin Nephrol 1992, 37(2): 84-89.","journal-title":"Clin Nephrol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1991.188","article-title":"Acanthocyturia - a characteristic marker for glomerular bleeding","volume":"40","author":"Kohler, H.; Wandel, E.; Brunk, B.","year":"1991","unstructured":"Kohler, H., Wandel, E. & Brunk, B. Acanthocyturia - a characteristic marker for glomerular bleeding. Kidney Int 1991, 40: 115-120.","journal-title":"Kidney Int"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1991.172","article-title":"Biological actions and pathophysiologic significance of endothelin in the kidney","volume":"40","author":"Kon, V.; Badr, K.F.","year":"1991","unstructured":"Kon, V. & Badr, K.F. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 1991, 40: 1-12.","journal-title":"Kidney Int"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198910193211614","article-title":"Plasma endothelin levels in patients with acute renal failure","volume":"321","author":"Tomita, K.; Ojile, K.; Nakanishi, T.","year":"1989","unstructured":"Tomita, K., Ojile, K., Nakanishi, T. et al. Plasma endothelin levels in patients with acute renal failure. NEnglJ Med 1989, 321: 1127.","journal-title":"NEnglJ Med"},{"key":"ref_7","first-page":"1611","article-title":"Pathophysiological role of endothelin in acute renal failure","volume":"46","author":"Shibouta, Y.; Suzuki, N.; Shino, A.","year":"1990","unstructured":"Shibouta, Y., Suzuki, N., Shino, A. et al. Pathophysiological role of endothelin in acute renal failure. Life Sci 1990, 46: 1611-1618.","journal-title":"Life Sci"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00041552-199210000-00019","article-title":"Prevention and attenuation of acute renal failure","volume":"1","author":"Wetzels, J.F.M.; Burke, T.J.; Schrier, R.W.","year":"1992","unstructured":"Wetzels, J.F.M., Burke, T.J. & Schrier, R.W. Prevention and attenuation of acute renal failure. Curr Opin Nephrol Hypertens 1992, 1: 133-140.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"757-590","key":"ref_9","first-page":"10","article-title":"Endothelium-derived relaxing and contracting factors: Perspectives in nephrology","volume":"39","author":"Luscher, T.F.; Bock, H.A.; Yang, Z.; Diederich, D.","year":"1991","unstructured":"Luscher, T.F., Bock, H.A., Yang, Z. & Diederich, D. Endothelium-derived relaxing and contracting factors: Perspectives in nephrology. Kidney Int 1991, 39: 757-590. 10 Rees, D.D., Palmer, R.M.J. & Moncada, S. The role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989, 86: 3375-3378.","journal-title":"Kidney Int; the regulation of blood pressure. Proc Natl Acad Sci; The role of endothelium-derived nitric oxide"},{"issue":"82","key":"ref_10","first-page":"532","article-title":"Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses ofacute renal failure","volume":"1988","author":"Conger, J.D.; Robinette, J.B.; Schrier, R.W.","unstructured":"Conger, J.D., Robinette, J.B. & Schrier, R.W. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses ofacute renal failure. J Clin Invest 1988, 82: 532-537.","journal-title":"J Clin Invest"},{"issue":"232","key":"ref_11","first-page":"708","article-title":"Selective blockade of endothelium dependent and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta","volume":"1985","author":"Martin, W.; Villani, G.M.; Jothianadan, D.; Furchgott, R.F.","unstructured":"Martin, W., Villani, G.M., Jothianadan, D. & Furchgott, R.F. Selective blockade of endothelium dependent and glyceryl trinitrate-induced relaxation by haemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985, 232: 708-716.","journal-title":"J Pharmacol Exp Ther"},{"issue":"233","key":"ref_12","first-page":"679","article-title":"Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous haemoproteins","volume":"1985","author":"Martin, W.; Villani, G.M.; Jothianadan, D.; Furchgott, R.F.","unstructured":"Martin, W., Villani, G.M., Jothianadan, D. & Furchgott, R.F. Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous haemoproteins. J Pharmacol Exp Ther 1985, 233: 679-685.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(91)92375-C","article-title":"Inhibition ofnitric oxide in septic shock: how much is beneficial?","volume":"338","author":"Nava, E.; Palmer, R.M.J.; Moncada, S.","year":"1991","unstructured":"Nava, E., Palmer, R.M.J. & Moncada, S. Inhibition ofnitric oxide in septic shock: how much is beneficial? Lancet 1991, 338: 1555-1557.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0140-6736(91)92376-D","article-title":"Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock","volume":"338","author":"Petros, A.; Bennet, D.; Vallance, P.","year":"1991","unstructured":"Petros, A., Bennet, D. & Vallance, P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991, 338: 1557-1558.","journal-title":"Lancet"},{"key":"ref_15","article-title":"Calcium antagonists and the kidney: implications for renal protection","author":"Epstein, M.","unstructured":"Epstein, M. Calcium antagonists and the kidney: implications for renal protection. Kidney Int 1992, 36 (Suppl): S66-S72."},{"key":"ref_16","first-page":"484","article-title":"Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat","volume":"255","author":"Shimizu, T.; Kawabata, T.; Nakamura, M.","year":"1990","unstructured":"Shimizu, T., Kawabata, T. & Nakamura, M. Protective effect of a novel calcium blocker, S-312-d, on ischemic acute renal failure in rat. J Pharmacol Exp Ther 1990, 255: 484-490.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref_17","article-title":"The role of calcium antagonists in nephrotoxic models of renal failure","volume-title":"Calcium Antagonists and the Kidney","author":"Michael, U.; Lee, S.M.","year":"1993","unstructured":"Michael, U. & Lee, S.M. The role of calcium antagonists in nephrotoxic models of renal failure. In: Epstein, M. & Loutzenhiser, R. (eds) Calcium Antagonists and the Kidney. Hanley & Belfus, 1993."},{"key":"ref_18","first-page":"1030","article-title":"Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial","volume":"4","author":"Neumayer, H.H.; Junge, W.; Kufner, A.; Wenning, A.","year":"1989","unstructured":"Neumayer, H.H., Junge, W., Kufner, A. & Wenning, A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial. Nephrol Dial Transplant 1989, 4: 1030-1036.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000167487","article-title":"Prevention of post-transplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomised study","volume":"7","author":"Wagner, K.; Albrecht, S.; Neumayer, H.","year":"1987","unstructured":"Wagner, K., Albrecht, S. & Neumayer, H. Prevention of post-transplant acute tubular necrosis by the calcium antagonist diltiazem: A prospective randomised study. Am J Nephrol 1987, 7: 287-291.","journal-title":"Am J Nephrol"},{"key":"ref_20","first-page":"11","article-title":"Calcium channel blockers for kidney protection","volume":"6","author":"Frei, U.; Harms, A.; Bakovic Alt, R.; Pichlmayr, R.; Koch, K.M.","year":"1990","unstructured":"Frei, U., Harms, A., Bakovic Alt, R., Pichlmayr, R. & Koch, K.M. Calcium channel blockers for kidney protection. J Cardiovasc Pharmacol 1990, 16 (Suppl 6): S11 -S15.","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ndt\/5.1.32","article-title":"Amelioration of postischaemic acute renal failure in conscious dogs by human atrial natriuretic peptide","volume":"5","author":"Neumayer, H.H.; Blossei, N.; Seherr Thohs, U.; Wagner, K.","year":"1990","unstructured":"Neumayer, H.H., Blossei, N., Seherr Thohs, U. & Wagner, K. Amelioration of postischaemic acute renal failure in conscious dogs by human atrial natriuretic peptide. Nephrol Dial Transplant 1990, 5: 32-38.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ki.1991.174","article-title":"Atrial natriuretic peptide and dopamine in established acute renal failure in the rat","volume":"40","author":"Conger, J.D.; Falk, S.A.; Hammond, W.S.","year":"1990","unstructured":"Conger, J.D., Falk, S.A. & Hammond, W.S. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 1990, 40: 21-28.","journal-title":"Kidney Int"},{"key":"ref_23","first-page":"1166","article-title":"Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure","volume":"255","author":"Pollock, D.M.; Opgenorth, T.J.","year":"1990","unstructured":"Pollock, D.M. & Opgenorth, T.J. Beneficial effect of the atrial natriuretic factor analog A68828 in postischemic acute renal failure. J Pharmacol Exp Ther 1990, 255: 1166-1169.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1748-1716.1990.tb08924.x","article-title":"The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat","volume":"139","author":"Bayati, A.; Nygren, K.; Kallskog, O.; Wolgast, M.","year":"1990","unstructured":"Bayati, A., Nygren, K., Kallskog, O. & Wolgast, M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand 1990, 139: 271-279.","journal-title":"Acta Physiol Scand"},{"key":"ref_25","first-page":"438","article-title":"Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity","volume":"259","author":"Coimbra, T.M.; Cieslinski, D.A.; Humes, H.D.","year":"1990","unstructured":"Coimbra, T.M., Cieslinski, D.A. & Humes, H.D. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 1990, 259: F438-F443.","journal-title":"Am J Physiol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0140-6736(91)93393-N","article-title":"Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure","volume":"337","author":"Storck, M.; Hartl, W.H.; Zimmerer, E.; Inthorn, D.","year":"1991","unstructured":"Storck, M., Hartl, W.H., Zimmerer, E. & Inthorn, D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991, 337: 452-455.","journal-title":"Lancet"},{"issue":"3","key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0272-6386(12)80089-8","article-title":"Selective elevation of monomeric IgAl in IgA nephropathy patients with normal renal function","volume":"18","author":"Peterman, J.H.; Julian, B.A.; Kirk, K.A.; Jackson, S.","year":"1991","unstructured":"Peterman, J.H., Julian, B.A., Kirk, K.A. & Jackson, S. Selective elevation of monomeric IgAl in IgA nephropathy patients with normal renal function. Am J Kidney Dis 1991, 18(3): 313-319.","journal-title":"Am J Kidney Dis"},{"issue":"85","key":"ref_28","first-page":"4865","article-title":"Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy","volume":"1988","author":"Cederholm, B.; Wieslander, J.; Bygrew, P.","unstructured":"Cederholm, B., Wieslander, J., Bygrew, P. et al. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci USA 1988, 85: 4865-4868.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0272-6386(12)80514-2","article-title":"Experimental glomerulonephritis induced by antigen that binds to glomerular fibronectin","volume":"15","author":"Cosio, F.G.; Mahan, J.D.; Sedmak, D.D.","year":"1990","unstructured":"Cosio, F.G., Mahan, J.D. & Sedmak, D.D. Experimental glomerulonephritis induced by antigen that binds to glomerular fibronectin. Am J Kidney Dis 1990, 15: 160-168.","journal-title":"Am J Kidney Dis"},{"key":"ref_30","first-page":"805","article-title":"Endothelial cell antigens recognised by IgA autoantibodies in patients with IgA nephropathy: partial characterization","volume":"7","author":"Wang, M.-X.; Walker, R.G.; Kincaid-Smith, P.","year":"1992","unstructured":"Wang, M.-X., Walker, R.G. & Kincaid-Smith, P. Endothelial cell antigens recognised by IgA autoantibodies in patients with IgA nephropathy: partial characterization. Nephrol Dial Transplant 1992, 7: 805-810.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_31","first-page":"466","article-title":"& The Glomerular Disease Collaborative Network. Serum IgA fibronectin aggregates in patients with IgA nephropathy and Henoch-Schonlein purpura: diagnostic value and pathogenic implications","author":"Jennette, J.C.; Wieslander, J.; Tuttle, R.; Falk, R.J.","year":"1991","unstructured":"Jennette, J.C., Wieslander, J., Tuttle, R., Falk, R.J. & The Glomerular Disease Collaborative Network. Serum IgA fibronectin aggregates in patients with IgA nephropathy and Henoch-Schonlein purpura: diagnostic value and pathogenic implications. Am J Kidney Dis 1991, XVIII (4): 466-471.","journal-title":"Am J Kidney Dis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5694\/j.1326-5377.1970.tb77780.x","article-title":"Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy","volume":"1","author":"Kincaid-Smith, P.; Laver, M.C.; Fairley, K.F.; Mathews, D.C.","year":"1970","unstructured":"Kincaid-Smith, P., Laver, M.C., Fairley, K.F. & Mathews, D.C. Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. A new approach to therapy. Med J Aust 1970, 1: 145-151.","journal-title":"Med J Aust"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000168079","article-title":"Detection of'activated platelets' in the urinary sediments using a scanning electron microscope in patients with IgA nephropathy","volume":"10","author":"Shirato, I.; Tomino, Y.; Koike, H.","year":"1990","unstructured":"Shirato, I., Tomino, Y. & Koike, H. Detection of'activated platelets' in the urinary sediments using a scanning electron microscope in patients with IgA nephropathy. Am JNephrol 1990, 10: 186-190.","journal-title":"Am JNephrol"},{"issue":"1","key":"ref_34","first-page":"8","article-title":"Urinary platelet factor four (PF4) levels in mesangial IgA glomerulonephritis and this basement membrane disease","volume":"37","author":"Taira, K.; Hewitson, T.D.; Kincaid-Smith, P.","year":"1992","unstructured":"Taira, K., Hewitson, T.D. & Kincaid-Smith, P. Urinary platelet factor four (PF4) levels in mesangial IgA glomerulonephritis and this basement membrane disease. Clin Nephrol 1992, 37(1): 8-13.","journal-title":"Clin Nephrol"},{"issue":"1","key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0272-6386(12)80284-8","article-title":"Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis","volume":"18","author":"Alambartine, E.; Sabatier, J.-C.; Guerin, C.; Berliet, J.-M.; Berthoux, F.","year":"1991","unstructured":"Alambartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M. & Berthoux, F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis. Am J Kidney Dis 1991, 18(1): 12-19.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"ref_36","first-page":"235","article-title":"Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy","volume":"37","author":"Okada, H.; Suzuki, H.; Konishi, K.; Sakaguchi, H.; Saruta, T.","year":"1992","unstructured":"Okada, H., Suzuki, H., Konishi, K., Sakaguchi, H. & Saruta, T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 1992, 37(5): 235-238.","journal-title":"Clin Nephrol"},{"key":"ref_37","first-page":"76","article-title":"Tubular proteinuria in IgA glomerulonephritis","volume":"27","author":"Nagy, J.; Milteny, M.; Dobos, M.","year":"1987","unstructured":"Nagy, J., Milteny, M., Dobos, M. et al. Tubular proteinuria in IgA glomerulonephritis. Clin Nephrol 1987, 27: 76-78.","journal-title":"Clin Nephrol"},{"issue":"1","key":"ref_38","first-page":"1","article-title":"The prognostic significance of urinary interleukin 6 in IgA nephropathy","volume":"35","author":"Dohi, K.; Iwano, M.; Muraguchi, A.","year":"1991","unstructured":"Dohi, K., Iwano, M., Muraguchi, A. et al. The prognostic significance of urinary interleukin 6 in IgA nephropathy. Clin Nephrol 1991, 35(1): 1-5.","journal-title":"Clin Nephrol"},{"issue":"1","key":"ref_39","first-page":"1","article-title":"C4A deficiency and poor prognosis in patients with IgA nephropathy","volume":"36","author":"Wyatt, R.J.; Julian, B.A.; Woodford, S.Y.","year":"1991","unstructured":"Wyatt, R.J., Julian, B.A., Woodford, S.Y. et al. C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 1991, 36(1): 1-5.","journal-title":"Clin Nephrol"},{"issue":"1","key":"ref_40","first-page":"6","article-title":"Pattern of proteinuria in IgA nephritis by SDS-PAGE: clinical significance","volume":"36","author":"Woo, K.T.; Lau, Y.K.; Lee, G.S.L.; Wei, S.S.; Lim, C.H.","year":"1991","unstructured":"Woo, K.T., Lau, Y.K., Lee, G.S.L., Wei, S.S. & Lim, C.H. Pattern of proteinuria in IgA nephritis by SDS-PAGE: clinical significance. Clin Nephrol 1991(a), 36(1): 6-11.","journal-title":"Clin Nephrol"},{"key":"ref_41","first-page":"6","article-title":"Effects of triple therapy in IgA nephritis a follow-up study 5 years later","volume":"36","author":"Woo, K.; Lee, G.; Lai, Y.; Chiang, G.; Lim, C.","year":"1991","unstructured":"Woo, K., Lee, G., Lai, Y., Chiang, G. & Lim, C. Effects of triple therapy in IgA nephritis a follow-up study 5 years later. Clin Nephrol 1991, 36: 6-66.","journal-title":"Clin Nephrol"},{"key":"ref_42","first-page":"47","article-title":"Metaanalysis of randomized controlled trials of patients with primary IgA nephropathy or Berger's disease","volume":"1","author":"Schena, F.P.; Montenegro, M.; Scivittaro, V.","year":"1990","unstructured":"Schena, F.P., Montenegro, M. & Scivittaro, V. Metaanalysis of randomized controlled trials of patients with primary IgA nephropathy or Berger's disease. Nephrol Dial Transplant 1990, Suppl 1: 47-52.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_43","first-page":"382","article-title":"IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases","volume":"7","author":"Kobayashi, Y.; Kiki, Y.; Fujii, K.; Kurokawa, A.; Kamiyana, M.; Tateno, S.","year":"1987","unstructured":"Kobayashi, Y., Kiki, Y., Fujii, K., Kurokawa, A., Kamiyana, M. & Tateno, S. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases. Seminars in Nephrology 1987, 7: 382-385.","journal-title":"Seminars in Nephrology"},{"issue":"26","key":"ref_44","first-page":"174","article-title":"Corticosteroid therapy in IgA nephropathy with nephrotic syndrome. A long term controlled trial","volume":"1986","author":"Lai, K.; Lai, F.; Ho, C.; Chan, K.","unstructured":"Lai, K., Lai, F., Ho, C. & Chan, K. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome. A long term controlled trial. Clin Nephrol 1986, 26: 174-180.","journal-title":"Clin Nephrol"},{"issue":"295","key":"ref_45","first-page":"1165","article-title":"Cyclosporin treatment of IgA nephropathy: a short term controlled trial","volume":"1987","author":"Lai, K.N.; Lai, F.M.M.; Li, P.K.; Vallance-Owen, J.","unstructured":"Lai, K.N., Lai, F.M.M., Li, P.K. & Vallance-Owen, J. Cyclosporin treatment of IgA nephropathy: a short term controlled trial. BMJ 1987, 295: 1165-1168.","journal-title":"BMJ"},{"key":"ref_46","first-page":"128","article-title":"Treatment of IgA nephropathy with Eicosapentanoic Acid (EPA): a two year prospective trial","volume":"31","author":"Bennet, W.M.; Walker, R.G.; Kincaid-Smith, P.","year":"1989","unstructured":"Bennet, W.M., Walker, R.G. & Kincaid-Smith, P. Treatment of IgA nephropathy with Eicosapentanoic Acid (EPA): a two year prospective trial. Clin Nephrol 1989, 31: 128-131.","journal-title":"Clin Nephrol"},{"issue":"5","key":"ref_47","first-page":"276","article-title":"Controlled trial of dipyridamole and low dose warfarin in patient with IgA nephritis with renal impairment","volume":"31","author":"Lee, G.S.; Woo, K.T.; Lim, C.H.","year":"1989","unstructured":"Lee, G.S., Woo, K.T. & Lim, C.H. Controlled trial of dipyridamole and low dose warfarin in patient with IgA nephritis with renal impairment. Clin Nephrol 1989, 31(5): 276.","journal-title":"Clin Nephrol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0272-6386(87)80145-2","article-title":"Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis","volume":"9","author":"Chan, M.; Kwan, S.; Chan, K.; Young, L.","year":"1987","unstructured":"Chan, M., Kwan, S., Chan, K. & Young, L. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis. Am J Kidney Dis 1987, 9: 417-421.","journal-title":"Am J Kidney Dis"},{"issue":"38","key":"ref_49","first-page":"30","article-title":"Phenytoin in IgA nephropathy: a long term controlled trial","volume":"1984","author":"Egido, J.; Rivera, F.; Sancho, J.; Barat, A.; Hernando, L.","unstructured":"Egido, J., Rivera, F., Sancho, J., Barat, A. & Hernando, L. Phenytoin in IgA nephropathy: a long term controlled trial. Nephron 1984, 38: 30-39.","journal-title":"Nephron"},{"issue":"538","key":"ref_50","first-page":"121","article-title":"Treatment of immunologically mediated glomerular disease","volume":"42","author":"Glassock, R.","year":"1992","unstructured":"Glassock, R. Treatment of immunologically mediated glomerular disease. Kidney Int 1992, 42(538): S121-S126.","journal-title":"Kidney Int"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotising glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey, C.D.; Rees, A.J.; Evans, D.J.; Peters, D.K.; Lockwood, C.M.","year":"1991","unstructured":"Pusey, C.D., Rees, A.J., Evans, D.J., Peters, D.K. & Lockwood, C.M. Plasma exchange in focal necrotising glomerulonephritis without anti-GBM antibodies. Kidney Int 1991, 40: 757-763.","journal-title":"Kidney Int"},{"issue":"10","key":"ref_52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM199209033271012","article-title":"HIV associated nephropathies","volume":"327","author":"Bourgoignie, J.J.; Pardo, V.","year":"1992","unstructured":"Bourgoignie, J.J. & Pardo, V. HIV associated nephropathies. N Engl J Med 1992, 327(10): 729-730.","journal-title":"N Engl J Med"},{"issue":"2","key":"ref_53","first-page":"69","article-title":"Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome","volume":"38","author":"Luke, D.R.; Sarnoski, T.P.; Dennis, S.","year":"1992","unstructured":"Luke, D.R., Sarnoski, T.P. & Dennis, S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol 1992, 38(2): 69-74.","journal-title":"Clin Nephrol"},{"issue":"35","key":"ref_54","first-page":"13","article-title":"Clinical features of human immunodeficiency virus associated nephropathy","volume":"40","author":"Rao, T.K.","year":"1991","unstructured":"Rao, T.K. Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 1991, 40(S35): S13-S18.","journal-title":"Kidney Int"},{"issue":"2","key":"ref_55","first-page":"61","article-title":"IgA nephritis in HIV positive patients: a new HIV associated nephropathy","volume":"38","author":"Katz, A.; Bargman, J.M.; Miller, D.C.; Guo, J.-W.; Ghali, V.S.; Schoeneman, M.J.","year":"1992","unstructured":"Katz, A., Bargman, J.M., Miller, D.C., Guo, J.-W., Ghali, V.S. & Schoeneman, M.J. IgA nephritis in HIV positive patients: a new HIV associated nephropathy. Clin Nephrol 1992, 38(2): 61-68.","journal-title":"Clin Nephrol"},{"issue":"10","key":"ref_56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM199209033271006","article-title":"Brief report: idiopathic IgA nephropathy in patients with human immunodeficiency virus infection","volume":"327","author":"Kimmel, P.L.; Phillips, T.M.; Ferreira-Centeno, A.; FarkasSzallasi, T.; Abraham, A.A.; Garrett, C.T.","year":"1992","unstructured":"Kimmel, P.L., Phillips, T.M., Ferreira-Centeno, A., FarkasSzallasi, T., Abraham, A.A. & Garrett, C.T. Brief report: idiopathic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 1992, 327(10): 702-706.","journal-title":"N Engl J Med"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1991.102","article-title":"Diagnostic significance of hypocomplementemia","volume":"39","author":"Hebert, L.A.; Cosio, F.G.; Neff, J.C.","year":"1991","unstructured":"Hebert, L.A., Cosio, F.G. & Neff, J.C. Diagnostic significance of hypocomplementemia. Kidney Int 1991, 39: 811-821.","journal-title":"Kidney Int"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.1991.126","article-title":"Circulating anti-entactin antibodies in patients with glomerulonephritis","volume":"39","author":"Saxena, R.; Bygren, P.; Cederholm, B.; Wieslander, J.","year":"1991","unstructured":"Saxena, R., Bygren, P., Cederholm, B., Wieslander, J. Circulating anti-entactin antibodies in patients with glomerulonephritis. Kidney Int 1991, 39: 996-1004.","journal-title":"Kidney Int"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ki.1991.242","article-title":"Elevated urinary excretion of the C5b-9 complex in membranous nephropathy","volume":"40","author":"true","year":"1991","unstructured":"Schulze, M., Donadio, J.V,. Pruchno, C.J. et al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991, 40: 533-538.","journal-title":"Kidney Int"},{"issue":"4","key":"ref_60","first-page":"\"pp. 313","article-title":"Antineutrophil cytoplasmic antibodies (ANCA): new tools in the diagnosis and follow-up of necrotising glomerulonephritis and vasculitis","volume":"37","author":"Kallenberg, C.G.M.; Tervaert, J.W.C.","year":"1992","unstructured":"Kallenberg, C.G.M. & Tervaert, J.W.C. Antineutrophil cytoplasmic antibodies (ANCA): new tools in the diagnosis and follow-up of necrotising glomerulonephritis and vasculitis. In: Andreucci, V.E. & Fine, L.G. (eds) International Yearbook of Nephrology. Springer-Verlag, London, 1992, pp. 313-336. 61a.Ulmex, M., Rautmann, A. & Gross, W.L., Immunodiagnostic aspects of autoantibodies against myeloperoxidase. Clin Nephrol 1992, 37(4): 161-168.","journal-title":"Clin Nephrol; International Yearbook of Nephrology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/6.10.689","article-title":"Anti neutrophil cytoplasmic antibodies and disease activity during longterm follow-up of 70 patients with systemic vasculitis","volume":"6","author":"Gaskin, G.; Savage, C.O.S.; Ryan, J.J.","year":"1991","unstructured":"Gaskin, G., Savage, C.O.S., Ryan, J.J. et al. Anti neutrophil cytoplasmic antibodies and disease activity during longterm follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991, 6: 689-694.","journal-title":"Nephrol Dial Transplant"},{"issue":"269","key":"ref_62","first-page":"767","article-title":"Antiphospholipid antibodies and disease","volume":"72","author":"Mackworth-Young, C.G.; Loizou, S.; Walport, M.J.","year":"1989","unstructured":"Mackworth-Young, C.G., Loizou, S. & Walport, M.J. Antiphospholipid antibodies and disease. Q J Med 1989, 72(269): 767-777.","journal-title":"Q J Med"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.V15777","article-title":"Anti-cardiolipin antibody and renal disease: a report of three cases","volume":"1","author":"D'Agati, V.; Kunis, C.; Williams, G.; Appel, G.B.","year":"1990","unstructured":"D'Agati, V., Kunis, C., Williams, G. & Appel, G.B. Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1990, 1: 777-784.","journal-title":"J Am Soc Nephrol"},{"key":"ref_64","article-title":"A phospholipid-beta2-glycoprotein-I complex is an antigen for cardiolipin antibodies occurring in autoimmune disease but not with infection","author":"Hunt, J.E.; McNeil, H.P.; Morgan, G.J.; Crameri, R.C.; Krilis, S.A.","year":"1993","unstructured":"Hunt, J.E., McNeil, H.P., Morgan, G.J., Crameri, R.C. & Krilis, S.A. A phospholipid-beta2-glycoprotein-I complex is an antigen for cardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1993 (in press).","journal-title":"Lupus"},{"key":"ref_65","first-page":"923","article-title":"Treatment of glomerular disease with cyclosporin. Nephrol Dial Transplant","volume":"4","author":"Meyrier, A.","year":"1989","unstructured":"Meyrier, A. Treatment of glomerular disease with cyclosporin. Nephrol Dial Transplant 1989, 4: 923-931."},{"key":"ref_66","first-page":"929","article-title":"Methyl prednisolone in patients with membranous nephropathy and declining renal function","volume":"65","author":"Short, C.; Soloman, L.; Gokal, R.; Mallick, N.P.","year":"1987","unstructured":"Short, C., Soloman, L., Gokal, R. & Mallick, N.P. Methyl prednisolone in patients with membranous nephropathy and declining renal function. Q J Med 1987, 65: 929-940.","journal-title":"Q J Med"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli, C.; Zucchelli, P.; Passerini, P.","year":"1989","unstructured":"Ponticelli, C., Zucchelli, P. & Passerini, P. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1989, 320: 8-13.","journal-title":"N Engl J Med"},{"issue":"5","key":"ref_68","first-page":"229","article-title":"Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis","volume":"37","author":"Murphy, B.F.; McDonald, I.; Fairley, K.F.; KincaidSmith, P.S.","year":"1992","unstructured":"Murphy, B.F., McDonald, I., Fairley, K.F. & KincaidSmith, P.S. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis. Clin Nephrol 1992, 37(5): 229-234.","journal-title":"Clin Nephrol"},{"issue":"3","key":"ref_69","first-page":"98","article-title":"Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety","volume":"35","author":"Palla, R.; Cirami, C.; Panichi, V.; Bianchi, A.M.; Parrini, M.; Grazi, G.","year":"1991","unstructured":"Palla, R., Cirami, C., Panichi, V., Bianchi, A.M., Parrini, M. & Grazi, G. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety. Clin Nephrol 1991, 35(3): 98-104.","journal-title":"Clin Nephrol"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000185830","article-title":"The effect oftreatment of corticosteroid resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with cyclosporin","volume":"54","author":"Walker, R.G.; Kincaid-Smith, P.","year":"1990","unstructured":"Walker, R.G. & Kincaid-Smith, P. The effect oftreatment of corticosteroid resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with cyclosporin. Nephron 1990, 54: 117-121.","journal-title":"Nephron"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.301.6753.635","article-title":"Sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy and their parents","volume":"301","author":"Walker, J.D.; Tariq, T.; Viberti, G.","year":"1990","unstructured":"Walker, J.D., Tariq, T. & Viberti, G. Sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy and their parents. Br Med J 1990, 301: 635-638.","journal-title":"Br Med J"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ndt\/7.7.597","article-title":"Lipoprotein (a) inpatients with proteinuria","volume":"7","author":"Thomas, M.E.; Freestone, A.; Varghese, Z.; Persaud, J.W.; Moorhead, J.F.","year":"1992","unstructured":"Thomas, M.E., Freestone, A., Varghese, Z., Persaud, J.W. & Moorhead, J.F. Lipoprotein (a) inpatients with proteinuria. Nephrol Dial Transplant 1992, 7: 597-601.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/oxfordjournals.ndt.a092102","article-title":"Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria","volume":"7","author":"Chan, P.C.K.; Robinson, J.D.; Yeung, W.C.; Cheng, I.K.; Yeung, H.W.D.; Tsang, M.T.S.","year":"1992","unstructured":"Chan, P.C.K., Robinson, J.D., Yeung, W.C., Cheng, I.K., Yeung, H.W.D. & Tsang, M.T.S. Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrol Dial Transplant 1992, 7: 93-99.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref_74","first-page":"274","article-title":"Lovastatin in the treatment of hypercholesterolaemia in nephrotic syndrome due to diabetic nephropathy stage IV-V","volume":"34","author":"Biesenbach, G.; Zazqornik, J.","year":"1992","unstructured":"Biesenbach, G. & Zazqornik, J. Lovastatin in the treatment of hypercholesterolaemia in nephrotic syndrome due to diabetic nephropathy stage IV-V. Clin Nephrol 1992, 34(6): 274-279.","journal-title":"Clin Nephrol"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High dose intravenous gammaglobulin for Kawasaki disease","volume":"i:","author":"Furusho, K.; Kamiy, T.; Nakano, H.","year":"1984","unstructured":"Furusho, K., Kamiy, T. & Nakano, H. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984, i: 1055-1058.","journal-title":"Lancet"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0140-6736(91)92797-6","article-title":"Treatment of systemic vasculitis with pooled intravenous immunoglobulin","volume":"337","author":"Jayne, D.R.W.; Davies, M.J.; Fox, C.J.V.; Black, C.M.; Lockwood, C.M.","year":"1991","unstructured":"Jayne, D.R.W., Davies, M.J., Fox, C.J.V., Black, C.M. & Lockwood, C.M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991, 337: 1137.","journal-title":"Lancet"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(88)92859-0","article-title":"Lupus anticoagulant and recurrent fetal loss: successful treatment with gamma globulin","volume":"ii:","author":"Carreras, L.O.; Perez, G.N.; Vega, H.R.","year":"1988","unstructured":"Carreras, L.O., Perez, G.N. & Vega, H.R. Lupus anticoagulant and recurrent fetal loss: successful treatment with gamma globulin. Lancet 1988, ii: 393-395.","journal-title":"Lancet"},{"key":"ref_78","first-page":"239","article-title":"Idiotipic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg)","volume":"21","author":"Kaveri, S.V.; Dietrich, G.; Jobin, D.; Rossi, F.; Sultan, Y.; Lockwood, C.M.; Kazatchkine, M.D.","year":"1992","unstructured":"Kaveri, S.V., Dietrich, G., Jobin, D., Rossi, F., Sultan, Y., Lockwood, C.M. & Kazatchkine, M.D. Idiotipic modulation of autoimmunity by therapeutic human immunoglobulin preparations (IVIg). In: Grunfeld, J.P., Bach, J.F., Kries, H. & Maxwell, M.H. (eds). Advances in Nephrology Mosby Year Book, St Louis, 1992, Vol. 21, pp. 239-346.","journal-title":"Advances in Nephrology Mosby Year Book, St Louis"},{"key":"ref_79","first-page":"2980","article-title":"Anti-idiotypes in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol","volume":"830","author":"Rossi, F.; Jayne, D.R.W.; Lockwood, C.M.; Hazatchkine, H.D.","year":"1991","unstructured":"Rossi, F., Jayne, D.R.W., Lockwood, C.M. & Hazatchkine, H.D. Anti-idiotypes in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 1991, 830: 2980-3030."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00041552-199210000-00016","article-title":"Management ofrenal disease and hypertension in insulin-dependent diabetes with emphasis on early nephropathy","volume":"1","author":"Mogensen, C.E.","year":"1992","unstructured":"Mogensen, C.E. Management ofrenal disease and hypertension in insulin-dependent diabetes with emphasis on early nephropathy. Curr Opin Nephrol Hypertens 1992, 1: 106-115.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/clinchem\/37.12.2048","article-title":"Borderline increase in albumin excretion rate and relation to glycaemic control in subjects with type 1 diabetes","volume":"37","author":"Chase, H.P.; Marshall, G.; Garg, S.K.; Harris, S.; Osberg, I.","year":"1991","unstructured":"Chase, H.P., Marshall, G., Garg, S.K., Harris, S. & Osberg, I. Borderline increase in albumin excretion rate and relation to glycaemic control in subjects with type 1 diabetes. Clin Chem 1991, 37: 2048-2052.","journal-title":"Clin Chem"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ki.1992.116","article-title":"Glomerular structure in type 1 (insulin dependent) diabetic patients with normoand microalbuminuria","volume":"41","author":"Walker, J.D.; Close, C.F.; Jones, S.L.","year":"1992","unstructured":"Walker, J.D., Close, C.F., Jones, S.L. et al. Glomerular structure in type 1 (insulin dependent) diabetic patients with normoand microalbuminuria. Kidney Int 1992, 41: 741-748.","journal-title":"Kidney Int"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ki.1990.217","article-title":"Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules","volume":"38","author":"Remuzzi, G.; Bertani, T.","year":"1990","unstructured":"Remuzzi, G. & Bertani, T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules. Kidney Int 1990, 38: 384-394.","journal-title":"Kidney Int"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ki.1992.130","article-title":"Ambulatory blood pressure in microalbuminuric type 1 diabetic patients","volume":"41","author":"Hansen, K.W.; Christensen, C.K.; Andersen, P.H.; Mau Pedersen, M.; Christensen, J.S.; Mogensen, C.E.","year":"1992","unstructured":"Hansen, K.W., Christensen, C.K., Andersen, P.H., Mau Pedersen, M., Christensen, J.S. & Mogensen, C.E. Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 1992, 41: 847-854.","journal-title":"Kidney Int"},{"issue":"318","key":"ref_85","first-page":"146","article-title":"Increased sodium-lithium countertransport in red cells of patients with insulin-dependent diabetes and nephropathy","volume":"1988","author":"Mangili, R.; Bending, J.J.; Scott, G.; Gupta, A.; Viberti, G.","unstructured":"Mangili, R., Bending, J.J., Scott, G., Gupta, A. & Viberti, G. Increased sodium-lithium countertransport in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988, 318: 146-150.","journal-title":"N Engl J Med"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1056\/NEJM199002223220803","article-title":"Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport","volume":"322","author":"Carr, S.; Mbanya, J.C.; Thomas, T.","year":"1990","unstructured":"Carr, S., Mbanya, J.C., Thomas, T. et al. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 1990, 322: 500-505.","journal-title":"N Engl J Med"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/cs0820301","article-title":"Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy","volume":"82","author":"Rutherford, P.A.; Thomas, T.H.; Carr, S.J.; Taylor, R.; Wilkinson, R.","year":"1992","unstructured":"Rutherford, P.A., Thomas, T.H., Carr, S.J., Taylor, R. & Wilkinson, R. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy. Clin Sci 1992, 82: 301-307.","journal-title":"Clin Sci"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.1991.17","article-title":"Red cell Na+\/Li+ countertransport in non-insulindependent diabetics with diabetic nephropathy","volume":"39","author":"Gall, M.A.; Rossing, P.; Jensen, J.S.; Funder, J.; Parving, H.H.","year":"1991","unstructured":"Gall, M.A., Rossing, P., Jensen, J.S., Funder, J. & Parving, H.H. Red cell Na+\/Li+ countertransport in non-insulindependent diabetics with diabetic nephropathy. Kidney Int 1991, 39: 135-140.","journal-title":"Kidney Int"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00500384","article-title":"Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy","volume":"34","author":"Elving, L.D.; Wetzels, J.F.; de Nobel, E.; Berden, J.H.","year":"1991","unstructured":"Elving, L.D., Wetzels, J.F., de Nobel, E. & Berden, J.H. Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991, 34: 126-128.","journal-title":"Diabetologia"},{"issue":"3","key":"ref_90","first-page":"340","article-title":"Elevated Vmax and Km for external sodium in red cell Na\/Li CTT in non-fasted insulin dependent (IDDM) patients with diabetic nephropathy","volume":"3","author":"Zerbini, G.; Laffel, L.; Canessa, M.","year":"1992","unstructured":"Zerbini, G., Laffel, L. & Canessa, M. Elevated Vmax and Km for external sodium in red cell Na\/Li CTT in non-fasted insulin dependent (IDDM) patients with diabetic nephropathy. J Am Soc Nephrol 1992, 3(3): 340.","journal-title":"J Am Soc Nephrol"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM199101103240202","article-title":"Effect of restricting dietary protein on the progression of renal failure in patients with insulindependent diabetes mellitus","volume":"324","author":"Zeller, K.; Whittaker, E.; Sullivan, L.; Raskin, P.; Jacobson, H.R.","year":"1991","unstructured":"Zeller, K., Whittaker, E., Sullivan, L., Raskin, P. & Jacobson, H.R. Effect of restricting dietary protein on the progression of renal failure in patients with insulindependent diabetes mellitus. N Engl J Med 1991, 324: 78-84.","journal-title":"N Engl J Med"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","article-title":"Renal protective effect of enalapril in diabetic nephropathy","volume":"304","author":"Bjorck, S.; Mulec, H.; Johnsen, S.A.A.; Norden, G.; Aurell, M.","year":"1992","unstructured":"Bjorck, S., Mulec, H., Johnsen, S.A.A., Norden, G. & Aurell, M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992, 304: 339-343.","journal-title":"Br Med J"},{"issue":"3","key":"ref_93","first-page":"335","article-title":"Enalapril slows the progression of renal disease in non-insulin dependent diabetes mellitus (NIDDM): Results of a 3-yr multicenter, randomised, prospective, double-blinded study","volume":"3","author":"Lebovitz, H.; Cnaan, A.; Wiegman, T.","year":"1992","unstructured":"Lebovitz, H., Cnaan, A., Wiegman, T. et al. Enalapril slows the progression of renal disease in non-insulin dependent diabetes mellitus (NIDDM): Results of a 3-yr multicenter, randomised, prospective, double-blinded study. J Am Soc Nephrol 1992, 3(3): 335.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref_94","first-page":"337","article-title":"Renal protective effects of captopril and metoprolol in diabetic nephropathy","volume":"3","author":"Parving, H.-H.; Rossing, P.; Hommel, E.; Smidt, U.M.","year":"1992","unstructured":"Parving, H.-H., Rossing, P., Hommel, E. & Smidt, U.M. Renal protective effects of captopril and metoprolol in diabetic nephropathy. J Am Soc Nephrol 1992, 3(3): 337.","journal-title":"J Am Soc Nephrol"},{"key":"ref_95","article-title":"Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into nondiabetic recipients","author":"Abouna, G.M.; Kremer, G.D.; Daddah, S.K.; Al-Adbabu, M.S.; Kunar, S.A.; Kusma, G.","year":"1983","unstructured":"Abouna, G.M., Kremer, G.D., Daddah, S.K., Al-Adbabu, M.S., Kunar, S.A. & Kusma, G. Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into nondiabetic recipients. Lancet 1983, ii: 1274.","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198907133210204","article-title":"Effects ofpancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes","volume":"321","author":"Bilous, R.; Mauer, S.M.; Sutherland, D.E.R.; Najarian, J.S.; Goetz, F.C.; Steffes, M.W.","year":"1989","unstructured":"Bilous, R., Mauer, S.M., Sutherland, D.E.R., Najarian, J.S., Goetz, F.C. & Steffes, M.W. Effects ofpancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989, 321: 80-85.","journal-title":"N Engl J Med"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ki.1992.135","article-title":"Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy","volume":"41","author":"Mau Pedersen, M.; Hansen, K.W.; Schmitz, A.; Sorensen, K.; Christensen, C.K.; Mogensen, C.E.","year":"1992","unstructured":"Mau Pedersen, M., Hansen, K.W., Schmitz, A., Sorensen, K., Christensen, C.K. & Mogensen, C.E. Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy. Kidney Int 1992, 41: 883-890.","journal-title":"Kidney Int"},{"issue":"3","key":"ref_98","first-page":"336","article-title":"Captopril delays progression to overt renal disease in insulin-dependent diabetes mellitus patients with microalbuminuria","volume":"3","author":"Mogensen, C.E.","year":"1992","unstructured":"Mogensen, C.E. Captopril delays progression to overt renal disease in insulin-dependent diabetes mellitus patients with microalbuminuria. J Am Soc Nephrol 1992, 3(3): 336. Wiedman, P., Boehlen, L., De Courten, M. & Shaw, S. Human diabetic proteinuria is affected differently by ACE inhibitors, calcium antagonists, or conventional therapy. J Am Soc Nephrol 1992, 3(3): 339.","journal-title":"J Am Soc Nephrol; Human diabetic proteinuria is affected differently by ACE inhibitors, calcium antagonists, or conventional therapy"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0272-6386(12)80051-5","article-title":"Autosomal dominant polycystic kidney disease - more than a renal disease","volume":"16","author":"Gabow, P.A.","year":"1990","unstructured":"Gabow, P.A. Autosomal dominant polycystic kidney disease - more than a renal disease. Am J Kidney Dis 1990, 16: 403-413.","journal-title":"Am J Kidney Dis"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0272-6386(87)80158-0","article-title":"Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease","volume":"9","author":"Gregoire, J.R.; Torres, V.E.; Holley, K.E.; Farrow, G.N.","year":"1987","unstructured":"Gregoire, J.R., Torres, V.E., Holley, K.E. & Farrow, G.N. Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987, 9: 27-38.","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"ref_101","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM199209243271303","article-title":"Intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"327","author":"Chapman, A.B.; Rubinstein, D.; Hughes, R.","year":"1992","unstructured":"Chapman, A.B., Rubinstein, D., Hughes, R. et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992, 327(13): 916-920.","journal-title":"N Engl J Med"},{"issue":"5","key":"ref_102","first-page":"245","article-title":"The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10 year follow-up in a five generation kindred","volume":"37","author":"Timio, M.; Monarca, C.; Pede, S.; Gentili, S.; Verdura, C.; Lolli, S.","year":"1992","unstructured":"Timio, M., Monarca, C., Pede, S., Gentili, S., Verdura, C. & Lolli, S. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10 year follow-up in a five generation kindred. Clin Nephrol 1992, 37(5): 245-251.","journal-title":"Clin Nephrol"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-92-2-202","article-title":"Diverticular disease in patients wtih chronic renal failure due to polycystic kidney disease","volume":"92","author":"Scheff, R.T.; Zuckerman, G.; Hartel, H.; Delmez, J.; Koehler, R.","year":"1980","unstructured":"Scheff, R.T., Zuckerman, G., Hartel, H., Delmez, J. & Koehler, R. Diverticular disease in patients wtih chronic renal failure due to polycystic kidney disease. Ann Intern Med 1980, 92: 202-204.","journal-title":"Ann Intern Med"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.1990.286","article-title":"Congenital hepatic fibrosis in autosomal dominant polycystic kidney disease","volume":"38","author":"Zerres, K.","year":"1990","unstructured":", 68: 741-746.","journal-title":"Kidney Int"},{"issue":"5","key":"ref_105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0272-6386(12)80956-5","article-title":"Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease","volume":"19","author":"Milutinovic, J.; Rust, P.F.; Fialkow, P.J.","year":"1992","unstructured":"& Zerres, K. Congenital hepatic fibrosis in autosomal dominant polycystic kidney disease. Kidney Int 1990, 38: 880-885.","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"ref_106","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199209243271310","article-title":"Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease","volume":"327","author":"Wiebers, D.O.; Torres, V.E.","year":"1992","unstructured":"Milutinovic, J., Rust, P.F., Fialkow, P.J. et al. Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992, 19(5): 465-472.","journal-title":"N Engl J Med"},{"key":"ref_107","first-page":"199","article-title":"Prediction oflikelihood of polycystic kidney disease in the fetus if a parent has autosomal dominant polycystic kidney disease","volume-title":"International Year Book of Nephrology","author":"Gabow, P.A.; Wilkins-Haug, L.","year":"1992","unstructured":"Wiebers, D.O. & Torres, V.E. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992, 327(13); 953-955."},{"key":"ref_108","first-page":"1048","article-title":"Elevated proto oncogene expression in polycystic kidneys of C57BL\/6J (CPK) mouse","volume":"I:","author":"Cowley, B.D.; Chadwick, L.J.; Grantham, J.J.; Calvet, J.P.","year":"1991","unstructured":"Gabow, P.A. & Wilkins-Haug, L. Prediction oflikelihood of polycystic kidney disease in the fetus if a parent has autosomal dominant polycystic kidney disease. In: Andreucci, V.E. & Fine, L.G. (eds) International Year Book of Nephrology. Springer-Verlag, London, 1992, pp. 199-207.","journal-title":"J Am Soc Nephrol"},{"issue":"33","key":"ref_109","first-page":"1130","article-title":"Mechanisms affecting the development of renal cystic disease induced by diphenyl thiazole","volume":"1988","author":"Torres, V.R.; Bernot, T.J.; Okamura, M.","unstructured":"Cowley, B.D., Chadwick, L.J., Grantham, J.J. & Calvet, J.P. Elevated proto oncogene expression in polycystic kidneys of C57BL\/6J (CPK) mouse. J Am Soc Nephrol 1991, I: 1048-1053.","journal-title":"Kidney Int"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.1991.306","article-title":"Polycystic kidney disease: clues to pathogenesis","volume":"40","author":"Gabow, P.A.","year":"1991","unstructured":"Torres, V.R., Bernot, T.J., Okamura, M. et al. Mechanisms affecting the development of renal cystic disease induced by diphenyl thiazole. Kidney Int 1988, 33: 1130-1139.","journal-title":"Kidney Int"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1992.28","article-title":"Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease","volume":"41","author":"Watson, M.L.; Macnicol, A.M.; Allan, P.L.; Wright, A.F.","year":"1992","unstructured":"Gabow, P.A. Polycystic kidney disease: clues to pathogenesis. Kidney Int 1991, 40: 989-996.","journal-title":"Kidney Int"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ki.1991.238","article-title":"Renal cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease","volume":"40","author":"Harrap, S.B.; Davies, D.L.; MacNicol, A.M.","year":"1991","unstructured":"Watson, M.L., Macnicol, A.M., Allan, P.L. & Wright, A.F. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 1992, 41: 206-210.","journal-title":"Kidney Int"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1681\/ASN.V271219","article-title":"Cyst decompression surgery for autosomal dominant polycystic kidney disease","volume":"2","author":"Elzinga, L.W.; Barry, J.M.; Torres, V.E.","year":"1992","unstructured":"Harrap, S.B., Davies, D.L., MacNicol, A.M. et al. Renal cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 1991, 40: 501-508.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref_114","first-page":"119","article-title":"Atherosclerotic renovascular disease causing renal impairment - a case for treatment","volume":"31","author":"Scoble, J.E.; Maher, E.R.; Hamilton, G.; Dick, R.; Sweny, P.; Moorhead, J.F.","year":"1989","unstructured":"Elzinga, L.W., Barry, J.M., Torres, V.E. et al. Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992, 2: 1219-1226.","journal-title":"Clin Nephrol"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1681\/ASN.V2111608","article-title":"Renal artery stenosis: prevelance and associated risk factors in patients undergoing routine cardiac catheterization","volume":"2","author":"Harding, M.B.; Smith, L.R.; Himmerstein, S.I.","year":"1992","unstructured":"Scoble, J.E., Maher, E.R., Hamilton, G., Dick, R., Sweny, P. & Moorhead, J.F. Atherosclerotic renovascular disease causing renal impairment - a case for treatment. Clin Nephrol 1989, 31(3): 119-122.","journal-title":"J Am Soc Nephrol"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/bmj.301.6762.1197","article-title":"Unsuspected renal artery stenosis in peripheral vascular disease","volume":"301","author":"Choudri, A.H.; Claland, J.G.F.; Rowlands, P.C.","year":"1990","unstructured":"Harding, M.B., Smith, L.R., Himmerstein, S.I. et al. Renal artery stenosis: prevelance and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992, 2: 1608-1616.","journal-title":"Br Med J"},{"key":"ref_117","first-page":"684","article-title":"Renal artery stenosis: an important finding in diabetic renal disease","volume":"17","author":"Brown, E.A.; Braun, M.; Cassar, J.; Wise, P.; Barratt, N.","year":"1992","unstructured":"Choudri, A.H., Claland, J.G.F., Rowlands, P.C. et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br Med J 1990, 301: 1197-1198.","journal-title":"Nephrol Dial and Transplant"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension)","volume":"338","author":"Dahlof, B.; Lindholm, L.H.; Hanson, L.","year":"1991","unstructured":"Brown, E.A., Braun, M., Cassar, J., Wise, P., Barratt, N. Renal artery stenosis: an important finding in diabetic renal disease. Nephrol Dial and Transplant 1992, 17: 684.","journal-title":"Lancet"},{"key":"ref_119","first-page":"\"3255","article-title":"Prevention of stroke by anti-hypertensive drug therapy in older persons with isolated systolic hypertension","volume":"265","author":"Group, Shep Cooperative Research","year":"1991","unstructured":"Dahlof, B., Lindholm, L.H., Hanson, L. et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 1991, 338: 1281-1285.","journal-title":"JAMA; Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularization"},{"issue":"282","key":"ref_120","first-page":"1013","article-title":"Renovascular disease and renal complications of angiotensin converting enzyme inhibitor therapy","volume":"77","author":"Kalra, P.A.; Mamtora, H.; Holmes, A.M.; Waldek, S.","year":"1990","unstructured":"Shep Cooperative Research Group. Prevention of stroke by anti-hypertensive drug therapy in older persons with isolated systolic hypertension. JAMA 1991, 265: 3255-3264. Pickering, T.G., Herman, L., Devereux, R.B. et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularization. Lancet 1988, ii, 551-552.","journal-title":"Q J Med"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.ndt.a092107","article-title":"Screening for renovascular disease with captopril-enhanced renography","volume":"7","author":"McLean, A.G.; Hilson, A.J.W.; Scoble, J.E.","year":"1992","unstructured":"Kalra, P.A., Mamtora, H., Holmes, A.M. & Waldek, S. Renovascular disease and renal complications of angiotensin converting enzyme inhibitor therapy. Q J Med 1990, 77(282): 1013-1018.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_122","first-page":"\"1365","article-title":"Cholesterol embolism","volume":"338","author":"Editorial","year":"1991","unstructured":"McLean, A.G., Hilson, A.J.W., Scoble, J.E. et al. Screening for renovascular disease with captopril-enhanced renography. Nephrol Dial Transplant 1992, 7: 211-215.","journal-title":"Lancet; Diminished operative risk and improved results following revascularisation for atherosclerotic renovascular disease"},{"issue":"21","key":"ref_123","first-page":"60","article-title":"Clinical course of atherosclerotic renovascular disease","volume":"1968","author":"Wollenwebber, J.; Sheps, S.G.; Davis, G.P.","unstructured":"Editorial. Cholesterol embolism. Lancet 1991, 338: 1365-1366. Novick, A.C., Khauli, R.B. & Vidt, D.G. Diminished operative risk and improved results following revascularisation for atherosclerotic renovascular disease. Urol Clin N Am 1984, 11(3): 435-449.","journal-title":"Am J Cardiol"},{"issue":"1","key":"ref_124","first-page":"1","article-title":"Management ofrenovascular disease","volume":"83","author":"Novick, A.C.","year":"1991","unstructured":"Wollenwebber, J., Sheps, S.G. & Davis, G.P. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 1968, 21: 60-71.","journal-title":"Circulation"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiology.181.2.1924796","article-title":"Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicentre study","volume":"181","author":"Rees, C.R.; Palmaz, J.C.; Becker, G.J.","year":"1991","unstructured":"Novick, A.C. Management ofrenovascular disease. Circulation 1991, 83(S1): 1-171.","journal-title":"Radiol"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/radiology.180.2.1829842","article-title":"Renal artery stenosis: preliminary results of treatment with the Strecker stent","volume":"180","author":"Kuhn, F.-P.; Kutkuhn, B.; Torsello, G.; Modder, V.","year":"1991","unstructured":"Rees, C.R., Palmaz, J.C., Becker, G.J. et al. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicentre study. Radiol 1991, 181: 507-514.","journal-title":"Radiol"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0002-9149(91)90167-J","article-title":"Progression and regression of minor coronary arterial narrowing by quantitative angiography after fenofibrate therapy","volume":"67","author":"Hahmann, H.W.; Bunte, T.; Hellwig, N.","year":"1991","unstructured":"Kuhn, F.-P., Kutkuhn, B., Torsello, G. & Modder, V. Renal artery stenosis: preliminary results of treatment with the Strecker stent. Radiol 1991, 180: 367-372.","journal-title":"Am J Cardiol"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1001\/jama.1987.03390230069027","article-title":"Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous by-pass grafts","volume":"257","author":"Blankenhorn, D.H.; Nessim, S.A.; Johnson, R.L.; Sanmarco, M.E.; Azan, S.P.; Cashin-Hemphill, L.","year":"1987","unstructured":"Hahmann, H.W., Bunte, T., Hellwig, N. et al. Progression and regression of minor coronary arterial narrowing by quantitative angiography after fenofibrate therapy. Am J Cardiol 1991, 67: 957-961.","journal-title":"J Am Med Assoc"},{"key":"ref_129","first-page":"5035","article-title":"Regression of atherosclerosis: a role for calcium antagonists","volume":"4","author":"Armstrong, M.L.; Heistad, D.D.; Lopez, J.A.G.","year":"1991","unstructured":"Blankenhorn, D.H., Nessim, S.A., Johnson, R.L., Sanmarco, M.E., Azan, S.P. & Cashin-Hemphill, L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous by-pass grafts. J Am Med Assoc 1987, 257: 3233-3240.","journal-title":"Am J Hypertension"},{"key":"ref_130","first-page":"7580","article-title":"Cloning and expression of the","volume-title":"human erythropoietin gene. Proc Natl Acad Sci 1985","volume":"92","author":"Lin, F.-K.; Suggs, S.; Lin, C.H.","unstructured":"Armstrong, M.L., Heistad, D.D. & Lopez, J.A.G. Regression of atherosclerosis: a role for calcium antagonists. Am J Hypertension 1991, 4: 5035-5115."},{"issue":"313","key":"ref_131","first-page":"806","article-title":"Isolation and characterisation of genomic and cDNA clones of human erythropoietin","volume":"1985","author":"Jacobs, K.; Shoemaker, C.; Rudersdorf, R.","unstructured":"Lin, F.-K., Suggs, S., Lin, C.H. et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci 1985, 92: 7580-7585.","journal-title":"Nature"},{"key":"ref_132","first-page":"2","article-title":"Effect ofhuman erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis","volume":"1986","author":"Winnearls, C.; Oliver, D.; Pippard, M.","unstructured":"Jacobs, K., Shoemaker, C., Rudersdorf, R. et al. Isolation and characterisation of genomic and cDNA clones of human erythropoietin. Nature 1985, 313: 806-810.","journal-title":"Lancet"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of anemia of end-stage renal disease with recombinant human erythropoietin","volume":"316","author":"Eschbach, J.W.; Egrie, J.; Downing, M.","year":"1987","unstructured":"Winnearls, C., Oliver, D., Pippard, M. et al. Effect ofhuman erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986, 2: 1175-1178.","journal-title":"N Engl J Med"},{"key":"ref_134","first-page":"1","article-title":"From protein to gene to protein: the molecular biology oferythropoietin","volume":"4","author":"Goldwasser, E.","year":"1991","unstructured":"Eschbach, J.W., Egrie, J., Downing, M. et al. Correction of anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987, 316: 73-78.","journal-title":"Am J Kidney Dis"},{"key":"ref_135","first-page":"1","article-title":"Erythropoietin: sites ofsynthesis and regulation ofsecretion","volume":"4","author":"Lacombe, C.; Da Silva, J.-L.; Bruneval, P.","year":"1991","unstructured":"Goldwasser, E. From protein to gene to protein: the molecular biology oferythropoietin. Am J Kidney Dis 1991, 4(Suppl 1): 10-13.","journal-title":"Am J Kidney Dis"},{"key":"ref_136","first-page":"1","article-title":"Mechanism of erythropoietin action","volume":"4","author":"Koury, M.J.; Bondurant, M.C.","year":"1991","unstructured":"Lacombe, C., Da Silva, J.-L., Bruneval, P. et al. Erythropoietin: sites ofsynthesis and regulation ofsecretion. Am J Kidney Dis 1991, 4(Suppl 1): 14-19.","journal-title":"Am J Kidney Dis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2796.1990.tb00192.x","article-title":"Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure","volume":"228","author":"Salmonson, T.; Danielson, B.G.; Grahnen, A.; Wikstrom, B.","year":"1990","unstructured":"Koury, M.J. & Bondurant, M.C. Mechanism of erythropoietin action. Am J Kidney Dis 1991, 4(Suppl 1): 20-23.","journal-title":"JIntern Med"},{"key":"ref_138","first-page":"113","article-title":"Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics","volume":"70","author":"Cotes, P.M.; Pippard, M.J.; Reid, C.D.","year":"1989","unstructured":"Salmonson, T., Danielson, B.G., Grahnen, A. & Wikstrom, B. Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure. JIntern Med 1990, 228: 53-57.","journal-title":"Q J Med"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0773.1990.tb00710.x","article-title":"Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients","volume":"66","author":"Nielsen, O.J.","year":"1990","unstructured":"Cotes, P.M., Pippard, M.J., Reid, C.D. et al. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med 1989, 70: 113-137.","journal-title":"Pharmacol Toxicol"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1681\/ASN.V291405","article-title":"Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration","volume":"2","author":"Besarab, A.; Flaharty, K.K.; Erslev, A.J.","year":"1992","unstructured":"Nielsen, O.J. Pharmacokinetics of recombinant human erythropoietin in chronic haemodialysis patients. Pharmacol Toxicol 1990, 66: 83-86.","journal-title":"J Am Soc Nephrol"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/oxfordjournals.ndt.a091888","article-title":"Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure","volume":"4","author":"Kindler, J.; Eckardt, K.U.; Ehmer, B.","year":"1989","unstructured":"Besarab, A., Flaharty, K.K., Erslev, A.J. et al. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: the case for subcutaneous administration. J Am Soc Nephrol 1992, 2: 1405-1416.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_142","first-page":"24","article-title":"National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group","volume":"18","author":"Nissenson, A.R.","year":"1991","unstructured":"Kindler, J., Eckardt, K.U., Ehmer, B. et al. Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure. Nephrol Dial Transplant 1989, 4: 345-349.","journal-title":"Am J Kidney Dis"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000168156","article-title":"Experience with low dose intravenous and subcutaneous administration of recombinant human erythropoietin","volume":"10","author":"McMahon, L.P.; Dawborn, J.K.","year":"1990","unstructured":"Nissenson, A.R., National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. Am J Kidney Dis 1991, 18: 24-33.","journal-title":"Am J Nephrol"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000169977","article-title":"Two years experience of daily self-administered subcutaneous erythropoietin","volume":"8","author":"Granolleras, C.; Branger, B.; Deschodt, G.","year":"1990","unstructured":"McMahon, L.P. & Dawborn, J.K. Experience with low dose intravenous and subcutaneous administration of recombinant human erythropoietin. Am J Nephrol 1990, 10: 404-408.","journal-title":"Blood Purif"},{"key":"ref_145","first-page":"1","article-title":"Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous","volume":"87","author":"Horl, W.H.","year":"1992","unstructured":"Granolleras, C., Branger, B., Deschodt, G. et al. Two years experience of daily self-administered subcutaneous erythropoietin. Blood Purif 1990, 8: 268-271.","journal-title":"Acta Haematol"},{"key":"ref_146","first-page":"457","article-title":"Mathematical modeling of erythropoietin therapy","volume":"37","author":"Garred, L.J.; Pretlac, R.","year":"1991","unstructured":"Horl, W.H. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous. Acta Haematol 1992, 87(Suppl 1): 16-19.","journal-title":"ASAIO Trans"},{"key":"ref_147","first-page":"181","article-title":"Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin","volume":"37","author":"Besarab, A.; Besarab, F.M.; Miller, D.","year":"1991","unstructured":"Garred, L.J. & Pretlac, R. Mathematical modeling of erythropoietin therapy. ASAIO Trans 1991, 37: M457-","journal-title":"ASAIO Trans"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ndt\/6.7.487","article-title":"Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patient with chronic renal failure maintained by continuous ambulatory peritoneal dialysis","volume":"6","author":"Stevens, J.M.; Auer, J.; Strong, C.A.","year":"1991","unstructured":"Besarab, A., Besarab, F.M. & Miller, D. Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin. ASAIO Trans 1991, 37: M181-M182.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_149","first-page":"200","article-title":"The use of subcutaneous erythropoietin in CAPD patients","volume":"33","author":"Piraino, B.; Johnston, J.R.","year":"1990","unstructured":"Stevens, J.M., Auer, J., Strong, C.A. et al. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patient with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991, 6: 487-494.","journal-title":"Clin Nephrol"},{"key":"ref_150","first-page":"405","article-title":"A double blind placebo controlled study of recombinant human erythropoietin in peritoneal dialysis patients","volume":"1","author":"Nissenson, A.R.; Swartz, R.; Zimmerman, S.W.","year":"1990","unstructured":"Piraino, B. & Johnston, J.R. The use of subcutaneous erythropoietin in CAPD patients. Clin Nephrol 1990, 33: 200-202.","journal-title":"J Am Soc Nephrol"},{"key":"ref_151","first-page":"47","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis","volume":"33","author":"Lui, S.F.; Chung, W.W.; Leung, C.B.; Chan, K.; Lai, K.N.","year":"1990","unstructured":"Nissenson, A.R., Swartz, R., Zimmerman, S.W. et al. A double blind placebo controlled study of recombinant human erythropoietin in peritoneal dialysis patients. J Am Soc Nephrol 1990, 1: 405(abstract).","journal-title":"Clin Nephrol"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(89)90014-7","article-title":"Pharmacokinetics of recombinant human erythropoietin in patients on continuous peritoneal dialysis","volume":"1","author":"MacDougall, I.C.; Roberts, D.E.; Robinson, M.I.","year":"1989","unstructured":"Lui, S.F., Chung, W.W., Leung, C.B., Chan, K. & Lai, K.N. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1990, 33: 47-51.","journal-title":"Lancet"},{"key":"ref_153","first-page":"246","article-title":"Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis","volume":"36","author":"Lui, S.F.; Law, C.B.; Ting, S.M.; Li, P.; Lai, K.N.","year":"1991","unstructured":"MacDougall, I.C., Roberts, D.E., Robinson, M.I. et al. Pharmacokinetics of recombinant human erythropoietin in patients on continuous peritoneal dialysis. Lancet 1989, 1: 425-427.","journal-title":"Clin Nephrol"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1681\/ASN.V2101545","article-title":"Erythropoietin for chronic ambulatory peritoneal dialysis patients: once a week can be enough","volume":"2","author":"Hood, V.L.; Ingraham, A.","year":"1992","unstructured":"Lui, S.F., Law, C.B., Ting, S.M., Li, P. & Lai, K.N. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991, 36: 246-251.","journal-title":"J Am Soc Nephrol"},{"key":"ref_155","first-page":"395","article-title":"Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients","volume":"37","author":"Besarab, A.; Golper, T.A.","year":"1991","unstructured":"Hood, V.L. & Ingraham, A. Erythropoietin for chronic ambulatory peritoneal dialysis patients: once a week can be enough. J Am Soc Nephrol 1992, 2: 1545-1546.","journal-title":"ASAIO Trans"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-9343(90)90371-J","article-title":"Treatment ofthe anemia ofchronic renal failure with subcutaneous recombinant human erythropoietin","volume":"89","author":"Watson, A.J.; Gimenez, L.F.; Cotton, S.; Walser, M.; Spivak, J.L.","year":"1990","unstructured":"Besarab, A. & Golper, T.A. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients. ASAIO Trans 1991, 37: M395-M396.","journal-title":"Am J Med"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000168067","article-title":"Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients","volume":"10","author":"Abraham, P.A.; Opsahl, J.A.; Rachael, K.M.; Asinger, R.; Halstenson, C.E.","year":"1990","unstructured":"Watson, A.J., Gimenez, L.F., Cotton, S., Walser, M. & Spivak, J.L. Treatment ofthe anemia ofchronic renal failure with subcutaneous recombinant human erythropoietin. Am J Med 1990, 89: 432-435.","journal-title":"Am J Nephrol"},{"key":"ref_158","first-page":"782","article-title":"Efficacy and tolerance of treatment with recombinanthuman erythropoietin in chronic renal failure (pre-dialysis) patients","volume":"4","author":"Frenken, L.A.; Verberckmoes, R.; Michielsen, P.; Koene, R.A.","year":"1989","unstructured":"Abraham, P.A., Opsahl, J.A., Rachael, K.M., Asinger, R. & Halstenson, C.E. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Am J Nephrol 1990, 10: 128-136.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0272-6386(89)80149-0","article-title":"The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial","volume":"14","author":"Kleinman, K.S.; Schweitzer, S.U.; Perdue, S.T.","year":"1989","unstructured":"Frenken, L.A., Verberckmoes, R., Michielsen, P. & Koene, R.A. Efficacy and tolerance of treatment with recombinanthuman erythropoietin in chronic renal failure (pre-dialysis) patients. Nephrol Dial Transplant 1989, 4: 782-786.","journal-title":"Am J Kidney Dis"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","article-title":"Treatment of the anemia of progressive renal failure with recombinant human erythropoietin","volume":"321","author":"Eschbach, J.W.; Kelly, M.R.; Haley, N.R.; Abels, R.I.; Adamson, J.W.","year":"1989","unstructured":"Kleinman, K.S., Schweitzer, S.U., Perdue, S.T. et al. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. Am J Kidney Dis 1989, 14: 486-495.","journal-title":"N Engl J Med"},{"issue":"4","key":"ref_161","first-page":"34","article-title":"Recombinant erythropoietin in predialysis patients","volume":"18","author":"Lim, V.S.","year":"1991","unstructured":"Eschbach, J.W., Kelly, M.R., Haley, N.R., Abels, R.I. & Adamson, J.W. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989, 321: 158-163.","journal-title":"Am J Kidney Dis"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0272-6386(13)80004-2","article-title":"Use of recombinant erythropoietin in thalassemic patients on dialysis","volume":"19","author":"Lai, K.N.; Wong, K.C.; Li, P.K.; Lui, S.F.","year":"1992","unstructured":"Lim, V.S. Recombinant erythropoietin in predialysis patients. Am J Kidney Dis 1991, 18(4)(Suppl 1): 34-37.","journal-title":"Am J Kidney"},{"key":"ref_163","first-page":"145","article-title":"Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease","volume":"37","author":"Holley, J.L.; Nolan, T.A.; Piraino, B.","year":"1992","unstructured":"Lai, K.N., Wong, K.C., Li, P.K. & Lui, S.F. Use of recombinant erythropoietin in thalassemic patients on dialysis. Am J Kidney 1992, 19: 239-245.","journal-title":"Clin Nephrol"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bmj.301.6750.476","article-title":"Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis","volume":"301","author":"Taylor, J.; Mactier, R.A.; Stewart, W.K.; Henderson, I.S.","year":"1990","unstructured":"Holley, J.L., Nolan, T.A. & Piraino, B. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease. Clin Nephrol 1992, 37:145-147.","journal-title":"Br Med J"},{"key":"ref_165","first-page":"252","article-title":"Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients","volume":"36","author":"Huraib, S.; Al Momen, A.K.; Gader, A.M.; Mitwalli, A.; Sulimani, F.; Abu Aisha, H.","year":"1991","unstructured":"Taylor, J., Mactier, R.A., Stewart, W.K. & Henderson, I.S. Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis. Br Med J 1990, 301: 476-477.","journal-title":"Clin Nephrol"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0140-6736(91)92239-X","article-title":"Erythropoietin and spontaneous platelet aggregation in haemodialysis patients","volume":"338","author":"Taylor, J.E.; Henderson, I.S.; Stewart, W.K.; Belch, J.J.","year":"1991","unstructured":"Huraib, S., Al Momen, A.K., Gader, A.M., Mitwalli, A., Sulimani, F. & Abu Aisha, H. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients. Clin Nephrol 1991, 36: 252-257.","journal-title":"Lancet"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0272-6386(12)80289-7","article-title":"Recombinant human erythropoietin to correct uremic bleeding","volume":"18","author":"Vigano, G.; Benigni, A.; Mendogni, D.; Mingardi, G.; Mecca, G.; Remuzzi, G.","year":"1991","unstructured":"Taylor, J.E., Henderson, I.S., Stewart, W.K. & Belch, J.J. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. Lancet 1991, 338: 1361-1362.","journal-title":"Am J Kidney Dis"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.1990.03440060071035","article-title":"The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group","volume":"263","author":"Evans, R.W.; Rader, B.; Manninen, D.L.","year":"1990","unstructured":"Vigano, G., Benigni, A., Mendogni, D., Mingardi, G., Mecca, G. & Remuzzi, G. Recombinant human erythropoietin to correct uremic bleeding. Am J Kidney Dis 1991, 18: 44-49.","journal-title":"JAMA"},{"key":"ref_169","first-page":"157","article-title":"Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients","volume":"36","author":"Deniston, O.L.; Luscombe, F.A.; Buesching, D.P.; Richner, R.E.; Spinowitz, B.S.","year":"1990","unstructured":"Evans, R.W., Rader, B. & Manninen, D.L. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 1990, 263: 825-830.","journal-title":"ASAIO Trans"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/089686089201200109","article-title":"Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia","volume":"12","author":"Auer, J.; Simon, G.; Stevens, J.","year":"1992","unstructured":"Deniston, O.L., Luscombe, F.A., Buesching, D.P., Richner, R.E. & Spinowitz, B.S. Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients. ASAIO Trans 1990, 36: M157-M160.","journal-title":"Perit Dial Int"},{"key":"ref_171","first-page":"16","article-title":"Quality of life and hematocrit level","volume":"20","author":"Levin, N.W.","year":"1992","unstructured":"Auer, J., Simon, G., Stevens, J. et al. Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia. Perit Dial Int 1992, 12: 40-42.","journal-title":"Am J Kidney Dis"},{"key":"ref_172","first-page":"\"573","article-title":"Canadian Erythropoietin Study Group. Assocation between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis","volume":"300","author":"Silberberg, J.; Racine, N.; Barre, P.; Sniderman, A.D.","year":"1990","unstructured":"Levin, N.W. Quality of life and hematocrit level. Am J Kidney Dis 1992, 20: 16-20.","journal-title":"Br Med J; Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0002-8703(92)90608-X","article-title":"Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin","volume":"124","author":"Goldberg, N.; Lundin, A.P.; Delano, B.; Friedman, E.A.; Stein, R.A.","year":"1992","unstructured":"Canadian Erythropoietin Study Group. Assocation between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990, 300: 573-578. Silberberg, J., Racine, N., Barre, P. & Sniderman, A.D. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 1990, 6: 1-4.","journal-title":"Am Heart J"},{"key":"ref_174","first-page":"402","article-title":"Detection of functional iron deficiency during Epo therapy. A new approach","volume":"1","author":"Macdougall, I.C.; Cavill, I.; Hulme, B.","year":"1990","unstructured":"Goldberg, N., Lundin, A.P., Delano, B., Friedman, E.A. & Stein, R.A. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 1992, 124: 424-427.","journal-title":"J Am Soc Nephrol"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0140-6736(90)90733-L","article-title":"Longterm cardiorespiratory effects of amelioration of renal anaemia by erythropoietin","volume":"335","author":"Macdougall, I.C.; Lewis, N.P.; Saunders, M.J.","year":"1990","unstructured":"Macdougall, I.C., Cavill, I., Hulme, B. et al. Detection of functional iron deficiency during Epo therapy. A new approach. J Am Soc Nephrol 1990, 1: 402.","journal-title":"Lancet"},{"key":"ref_176","first-page":"76","article-title":"Effects of erythropoietin on blood pressure","volume":"18","author":"Raine, A.E.; Roger, S.D.","year":"1991","unstructured":"Macdougall, I.C., Lewis, N.P., Saunders, M.J. et al. Longterm cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet 1990, 335: 489-493.","journal-title":"Am J Kidney Dis"},{"key":"ref_177","first-page":"293","article-title":"Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment ofanemic hemodialysis patients","volume":"33","author":"Hori, K.; Onoyama, K.; Iseki, K.; Fujimi, S.; Fujishima, M.","year":"1990","unstructured":"Raine, A.E. & Roger, S.D. Effects of erythropoietin on blood pressure. Am J Kidney Dis 1991, 18: 76-83.","journal-title":"Clin Nephrol"},{"key":"ref_178","first-page":"190","article-title":"Correction of the anaemia in haemodialysis patients with recombinant human erythropoietin: haemodynamic changes and risks for hypertension","volume":"35","author":"Buckner, F.F.; Eschbach, J.W.; Haley, N.R.","year":"1989","unstructured":"Hori, K., Onoyama, K., Iseki, K., Fujimi, S. & Fujishima, M. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment ofanemic hemodialysis patients. Clin Nephrol 1990, 33: 293-298.","journal-title":"Kidney Int"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ki.1989.274","article-title":"Vascular changes in hemodialysis patients in response to recombinant human erythropoietin","volume":"36","author":"London, G.M.; Zins, B.; Pannier, B.","year":"1989","unstructured":"Buckner, F.F., Eschbach, J.W., Haley, N.R. et al. Correction of the anaemia in haemodialysis patients with recombinant human erythropoietin: haemodynamic changes and risks for hypertension. Kidney Int 1989, 35: 190.","journal-title":"Kidney Int"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2796.1992.tb01246.x","article-title":"Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin","volume":"231","author":"Linde, T.G.; Sandhagen, B.; Danielson, B.G.; Wikstrom, B.","year":"1992","unstructured":"London, G.M., Zins, B., Pannier, B. et al. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 1989, 36: 878-882.","journal-title":"J Intern Med"},{"key":"ref_181","first-page":"2","article-title":"Clinical and blood rheologic stability in erythropoietin-treated predialysis patients","volume":"10","author":"Brown, C.D.; Friedman, E.A.","year":"1990","unstructured":"Linde, T.G., Sandhagen, B., Danielson, B.G. & Wikstrom, B. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin. J Intern Med 1992, 231: 601-606.","journal-title":"Am J Neprhol"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2362.1990.tb02272.x","article-title":"Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin","volume":"20","author":"Creutzig, A.; Caspary, L.; Nonnast Daniel, B.","year":"1990","unstructured":"Brown, C.D. & Friedman, E.A. Clinical and blood rheologic stability in erythropoietin-treated predialysis patients. Am J Neprhol 1990, 10(Suppl 2): 29-33.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"ref_183","first-page":"135","article-title":"Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis","volume":"30","author":"Fritschka, E.; Neumayer, H.H.; Seddighi, S.; Thiede, H.M.; Distler, A.; Philipp, T.","year":"1990","unstructured":"Creutzig, A., Caspary, L., Nonnast Daniel, B. et al. Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin. Eur J Clin Invest 1990, 20: 219-223.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_184","first-page":"614","article-title":"Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal aanemia","volume":"14","author":"Muller, R.; Steffen, H.M.; Brunner, R.","year":"1991","unstructured":"Fritschka, E., Neumayer, H.H., Seddighi, S., Thiede, H.M., Distler, A. & Philipp, T. Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis. Br J Clin Pharmacol 1990, 30(Suppl 1): 135S-138S.","journal-title":"Clin Invest Med"},{"key":"ref_185","first-page":"1065","article-title":"Seizures in haemodialysis patients treated with recombinant human erythropoietin","volume":"4","author":"Edmunds, M.E.; Wallis, J.; Tucker, B.","year":"1989","unstructured":"Muller, R., Steffen, H.M., Brunner, R. et al. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal aanemia. Clin Invest Med 1991, 14: 614-622.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bmj.1.5852.507","article-title":"Autoregulation of the brain circulation in severe arterial hypertension","volume":"1","author":"Strandgaard, S.; Oleson, J.; Skinhoj, E.","year":"1973","unstructured":", 1: 990-998.","journal-title":"Br Med J"},{"key":"ref_187","first-page":"737","article-title":"CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO","volume":"262","author":"Hirakata, H.; Yao, H.; Osato, S.","year":"1992","unstructured":"Edmunds, M.E., Wallis, J., Tucker, B. et al. Seizures in haemodialysis patients treated with recombinant human erythropoietin. Nephrol Dial Transplant 1989, 4: 1065-1069.","journal-title":"Am J Physiol"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ki.1990.291","article-title":"Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability","volume":"38","author":"Johnson, W.J.; McCarthy, J.T.; Yanagihara, T.","year":"1990","unstructured":"Strandgaard, S., Oleson, J., Skinhoj, E. et al. Autoregulation of the brain circulation in severe arterial hypertension. Br Med J 1973, 1: 507-510.","journal-title":"Kidney Int"},{"issue":"4","key":"ref_189","first-page":"84","article-title":"Side effects of erythropoietin therapy","volume":"18","author":"Bennett, W.M.","year":"1991","unstructured":"Hirakata, H., Yao, H., Osato, S. et al. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol 1992, 262: F737-F743.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"ref_190","first-page":"71","article-title":"Impact of erythropoietin on dialysis prescription","volume":"18","author":"Van Wyck, D.B.","year":"1991","unstructured":"Johnson, W.J., McCarthy, J.T., Yanagihara, T. et al. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int 1990, 38: 919-924.","journal-title":"Am J Kidney Dis"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/ki.1990.149","article-title":"Effect of hematocrit on solute removal during high efficiency hemodialysis","volume":"37","author":"Lim, V.S.; Flanigan, M.J.; Fangman, J.","year":"1990","unstructured":"Bennett, W.M. Side effects of erythropoietin therapy. Am J Kidney Dis 1991, 18 (4 Suppl 1): 84-86.","journal-title":"Kidney Int"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/089686089201200210","article-title":"The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis","volume":"12","author":"Hutchison, A.J.; Ofsthun, N.J.; Howarth, D.; Gokal, R.","year":"1992","unstructured":"Van Wyck, D.B. Impact of erythropoietin on dialysis prescription. Am J Kidney Dis 1991, 18 (4 Suppl 1): 71-75.","journal-title":"Perit Dial Int"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/089686089201200208","article-title":"Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin","volume":"12","author":"Taylor, J.E.; Mactier, R.A.; Henderson, I.S.; Belch, J.J.; Stewart, W.K.","year":"1992","unstructured":"Lim, V.S., Flanigan, M.J. & Fangman, J. Effect of hematocrit on solute removal during high efficiency hemodialysis. Kidney Int 1990, 37: 1557-1562.","journal-title":"Perit Dial Int"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(12)80652-4","article-title":"The effect of hematocrit on peritoneal transport","volume":"18","author":"Korbet, S.M.; Vonesh, E.F.; Firanek, C.A.","year":"1991","unstructured":"Hutchison, A.J., Ofsthun, N.J., Howarth, D. & Gokal, R. The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992, 12: 230-233.","journal-title":"Am J Kidney Dis"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000185716","article-title":"Increased ultrafiltration after erythropoietin-induced correction of renal anaemia in patients on continuous ambulatory peritoneal dialysis","volume":"53","author":"Steinhauer, H.B.; Lubrich-Birkner, I.; Dreyling, K.W.","year":"1989","unstructured":"Taylor, J.E., Mactier, R.A., Henderson, I.S., Belch, J.J. & Stewart, W.K. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin. Perit Dial Int 1992, 12: 221-226.","journal-title":"Nephron"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.1991.tb08093.x","article-title":"Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin","volume":"79","author":"Kooistra, M.P.; van Es, A.; Struyvenberg, A.; Marx, J.J.","year":"1991","unstructured":"Korbet, S.M., Vonesh, E.F. & Firanek, C.A. The effect of hematocrit on peritoneal transport. Am J Kidney Dis 1991, 18: 573-578.","journal-title":"Br J Haematol"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2257.1991.tb00280.x","article-title":"Sub-optimal doses ofhuman recombinant erythropoietin markedly lower serum ferritin","volume":"13","author":"Jones Lecointe, A.; Green, P.J.; Lee, H.A.","year":"1991","unstructured":"Steinhauer, H.B., Lubrich-Birkner, I., Dreyling, K.W. et al. Increased ultrafiltration after erythropoietin-induced correction of renal anaemia in patients on continuous ambulatory peritoneal dialysis. Nephron 1989, 53: 91-92.","journal-title":"Clin Lab Haematol"},{"key":"ref_198","first-page":"87","article-title":"Modulating factors in the hematopoietic response to erythropoietin","volume":"18","author":"Drueke, T.B.","year":"1991","unstructured":"Kooistra, M.P., van Es, A., Struyvenberg, A. & Marx, J.J. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991, 79: 634-639.","journal-title":"Am J Kidney Dis"},{"key":"ref_199","first-page":"8","article-title":"Resistance to recombinant human erythropoietin: a real clinical entity?","volume":"9","author":"Stivelman, J.C.","year":"1989","unstructured":"Jones Lecointe, A., Green, P.J. & Lee, H.A. Sub-optimal doses ofhuman recombinant erythropoietin markedly lower serum ferritin. Clin Lab Haematol 1991, 13: 251-253.","journal-title":"Semin Nephrol"},{"key":"ref_200","first-page":"438","article-title":"Erythropoietin fails to reverse the anaemia in mice continuously exposed to tumor necrosis factor-alpha in vivo. Exp Haematol 1990,18","author":"Clibon, U.; Bonewald, L.; Caro, J.","unstructured":"Drueke, T.B. Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis 1991, 18: 87-92."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.1987.tb02289.x","article-title":"Inhibition by interleukin-l of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias","volume":"67","author":"Schooley, J.C.; Kullgren, B.; Allison, A.C.","year":"1987","unstructured":"Stivelman, J.C. Resistance to recombinant human erythropoietin: a real clinical entity? Semin Nephrol 1989, 9: 8-11.","journal-title":"Br J Haematol"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0002-9343(90)90190-O","article-title":"Hepatitis related hepatic erythropoietin production","volume":"89","author":"Klassen, D.K.; Spivac, J.L.","year":"1990","unstructured":"Clibon, U., Bonewald, L., Caro, J. et al. Erythropoietin fails to reverse the anaemia in mice continuously exposed to tumor necrosis factor-alpha in vivo. Exp Haematol 1990,18: 438-441.","journal-title":"Am J Med"},{"issue":"82","key":"ref_203","first-page":"4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for pre-pro parathyroid hormone in isolated bovine parathyroid cells","volume":"1985","author":"Silver, J.; Russell, J.; Sherwood, L.M.","unstructured":"Schooley, J.C., Kullgren, B. & Allison, A.C. Inhibition by interleukin-l of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias. Br J Haematol 1987, 67: 11-17.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-(OH)2D3 in parathyroid glands of patients with renal failure","volume":"316","author":"Korkor, A.B.","year":"1987","unstructured":"Klassen, D.K. & Spivac, J.L. Hepatitis related hepatic erythropoietin production. Am J Med 1990, 89: 684-686.","journal-title":"N Engl J Med"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ki.1989.3","article-title":"1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs","volume":"35","author":"Brown, A.J.; Dusso, A.; Lopez Hilker, S.; Lewis Finch, J.; Grooms, P.; Slatopolsky, E.","year":"1989","unstructured":"Silver, J., Russell, J. & Sherwood, L.M. Regulation by vitamin D metabolites of messenger ribonucleic acid for pre-pro parathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 1985, 82:4270-4273.","journal-title":"Kidney Int"},{"issue":"3","key":"ref_206","first-page":"696","article-title":"The mechanism of decreased calcitriol receptor concentration in renal failure","volume":"3","author":"Hsu, C.H.; Patel, S.; Vanholder, R.","year":"1992","unstructured":"Korkor, A.B. Reduced binding of [3H]1,25-(OH)2D3 in parathyroid glands of patients with renal failure. N Engl J Med 1987, 316: 1573-1577.","journal-title":"J Am Soc Nephrol"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ki.1991.110","article-title":"Regulation of parathyroid hormone synthesis in chronic renal failure in rats","volume":"39","author":"Fukagawa, M.; Kaname, S.; Igarashi, T.; Ogata, E.; Kurokawa, K.","year":"1991","unstructured":"Brown, A.J., Dusso, A., Lopez Hilker, S., Lewis Finch, J., Grooms, P. & Slatopolsky, E. 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989, 35: 19-23.","journal-title":"Kidney Int"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo","volume":"86","author":"Navey-Many, T.; Marks, R.; Keshet, E.; Pike, J.W.; Silver, J.","year":"1990","unstructured":"Hsu, C.H., Patel, S. & Vanholder, R. The mechanism of decreased calcitriol receptor concentration in renal failure. J Am Soc Nephrol 1992, 3(3): 696.","journal-title":"J Clin Invest"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25 dihydroxyvitamin D. A role for increased sensitivity to calcium","volume":"83","author":"Delmez, A.J.; Tindira, C.; Grooms, P.; Dusso, A.; Windus, D.W.; Slatopolsky, E.","year":"1989","unstructured":"Fukagawa, M., Kaname, S., Igarashi, T., Ogata, E. & Kurokawa, K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 1991, 39: 874-881.","journal-title":"J Clin Invest"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ki.1989.305","article-title":"Direct inhibitory effect ofcalcitriol on parathyroid function (sigmoidal curve) in dialysis","volume":"36","author":"Dunlay, R.; Rodriguez, M.; Felsenfeld, A.J.; Llach, F.","year":"1989","unstructured":"Navey-Many, T., Marks, R., Keshet, E., Pike, J.W. & Silver, J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 1990, 86: 1968-1975.","journal-title":"Kidney Int"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ki.1991.203","article-title":"Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat","volume":"40","author":"Rodriguez, M.; Felsenfeld, A.J.; Torres, A.; Pederson, L.; Llach, F.","year":"1991","unstructured":"Delmez, A.J., Tindira, C., Grooms, P., Dusso, A., Windus, D.W. & Slatopolsky, E. Parathyroid hormone suppression by intravenous 1,25 dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 1989, 83: 1349-1355.","journal-title":"Kidney Int"},{"issue":"3","key":"ref_212","first-page":"692","article-title":"The effect of azotaemia and the magnitude of hyperparathyroidism on the calcaemic response to parathyroid hormone","volume":"3","author":"Bover, J.; Trinidad, R.; Felsenfeld, A.; Rodriguez, M.; Llach, F.","year":"1992","unstructured":"Dunlay, R., Rodriguez, M., Felsenfeld, A.J. & Llach, F. Direct inhibitory effect ofcalcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 1989, 36: 1093-1098.","journal-title":"J Am Soc Nephrol"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1991.314","article-title":"Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol","volume":"40","author":"Rodriguez, M.; Martin Malo, A.; Martinez, M.E.; Torres, A.; Felsenfeld, A.J.; Llach, F.","year":"1991","unstructured":"Rodriguez, M., Felsenfeld, A.J., Torres, A., Pederson, L. & Llach, F. Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat. Kidney Int 1991, 40: 219-225.","journal-title":"Kidney Int"},{"key":"ref_214","first-page":"432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent ofchanges in calcium and calcitriol","volume":"28","author":"Lopez-Hilker, S.; Dusso, A.; Rapp, N.; Martin, K.J.; Slatopolsky, E.","year":"1990","unstructured":"Bover, J., Trinidad, R., Felsenfeld, A., Rodriguez, M. & Llach, F. The effect of azotaemia and the magnitude of hyperparathyroidism on the calcaemic response to parathyroid hormone. J Am Soc Nephrol 1992, 3(3): 692.","journal-title":"Am J Physiol"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(12)80446-X","article-title":"Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease","volume":"19","author":"Delmez, J.A.; Slatopolsky, E.","year":"1992","unstructured":"Rodriguez, M., Martin Malo, A., Martinez, M.E., Torres, A., Felsenfeld, A.J. & Llach, F. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Kidney Int 1991, 40: 1055-1062.","journal-title":"Am J Kidney Dis"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365599209180396","article-title":"Serum concentrations of calcitriol and PTH in hemo-dialysis patients on treatment with calcium carbonate","volume":"26","author":"Wilske, J.; Bjorck, S.; Delin, K.","year":"1992","unstructured":"Lopez-Hilker, S., Dusso, A., Rapp, N., Martin, K.J. & Slatopolsky, E. Phosphorus restriction reverses hyperparathyroidism in uremia independent ofchanges in calcium and calcitriol. Am J Physiol 1990, 28: F432-F437.","journal-title":"Scand J Urol Nephrol"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-6386(12)80059-X","article-title":"Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy","volume":"16","author":"Meric, F.; Yap, P.; Bia, M.J.","year":"1990","unstructured":"Delmez, J.A. & Slatopolsky, E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992, 19: 303-317.","journal-title":"Am J Kidney Dis"},{"issue":"83","key":"ref_218","first-page":"66","article-title":"Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study","volume":"1989","author":"Sheikh, M.S.; Maguire, J.A.; Emmett, K.","unstructured":"Wilske, J., Bjorck, S. & Delin, K. Serum concentrations of calcitriol and PTH in hemo-dialysis patients on treatment with calcium carbonate. Scand J Urol Nephrol 1992, 26: 51-54.","journal-title":"J Clin Invest"},{"key":"ref_219","first-page":"690","article-title":"Calcium acetate, an effective phosphorus binder in patients with renal failure","volume":"36","author":"Mai, M.L.; Emmett, M.; Sheikh, M.S.; Santa Ana, C.A.; Schiller, L.; Fordtran, J.S.","year":"1989","unstructured":"Meric, F., Yap, P. & Bia, M.J. Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 1990, 16: 459-464."},{"key":"ref_220","first-page":"\"6","article-title":"Control of predialysis hyperphosphataemia by oral calcium acetate and calcium carbonate","volume":"60","author":"Moriniere, Ph; Djeras, M.; Boudaillez, B.","year":"1992","unstructured":"Sheikh, M.S., Maguire, J.A., Emmett, K. et al. Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. J Clin Invest 1989,83: 66-73.","journal-title":"Nephron; High dose calcium carbonate with stepwise reduction in dialysate calcium concentration: the effect on phosphate control and aluminium avoidance in haemodialysis patients"},{"key":"ref_221","first-page":"48","article-title":"Calcium mass transfer in peritoneal dialysis using 2.5 mEq\/l calcium dialysate","volume":"37","author":"Piraino, B.; Bernardini, J.; Holley, J.; Johnson, J.R.; Perlmutter, J.A.; Martes, L.","year":"1992","unstructured":"Mai, M.L., Emmett, M., Sheikh, M.S., Santa Ana, C.A., Schiller, L. & Fordtran, J.S. Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 1989, 36: 690-695.","journal-title":"Clin Nephrol"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress, D.L.; Norris, K.C.; Coburn, J.W.; Slatopolsky, E.A.; Sherrard, D.J.","year":"1989","unstructured":"Moriniere, Ph., Djeras, M., Boudaillez, B. et al. Control of predialysis hyperphosphataemia by oral calcium acetate and calcium carbonate. Nephron 1992, 60: 6-11. Sawyer, N., Noonan, K., Altman, P., Marsh, F. & Cunningham, J. High dose calcium carbonate with stepwise reduction in dialysate calcium concentration: the effect on phosphate control and aluminium avoidance in haemodialysis patients. Nephrol Dial Transplant 1989, 4: 105-109.","journal-title":"N Engl J Med"},{"issue":"3","key":"ref_223","first-page":"699","article-title":"Intermittent versus continuous administration of 1,25(OH)2D3. Comparison of efficiency","volume":"3","author":"Reichel, H.; Szabo, A.; Pesian, S.","year":"1992","unstructured":"Piraino, B., Bernardini, J., Holley, J., Johnson, J.R., Perlmutter, J.A. & Martes, L. Calcium mass transfer in peritoneal dialysis using 2.5 mEq\/l calcium dialysate. Clin Nephrol 1992, 37: 48-51.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref_224","first-page":"700","article-title":"The effect of long-term calcitriol administration after haemodialysis on parathyroid function","volume":"3","author":"Rodriguez, A.P.; Lorenzo, V.; Concepcion, M.T.","year":"1992","unstructured":"Andress, D.L., Norris, K.C., Coburn, J.W., Slatopolsky, E.A. & Sherrard, D.J. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989, 321: 274-279.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref_225","first-page":"697","article-title":"Evidence for tolerance to pulsed oral calcitriol in haemodialysis patients","volume":"3","author":"Kwan, J.T.C.; Almond, M.K.; Beer, J.; Cunningham, J.","year":"1992","unstructured":"Reichel, H., Szabo, A., Pesian, S. et al. Intermittent versus continuous administration of 1,25(OH)2D3. Comparison of efficiency. J Am Soc Nephrol 1992, 3(3): 699.","journal-title":"J Am Soc Nephrol"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000186767","article-title":"Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure","volume":"60","author":"Varghese, Z.; Moorhead, J.F.; Farrington, K.","year":"1992","unstructured":"Rodriguez, A.P., Lorenzo, V., Concepcion, M.T. et al. The effect of long-term calcitriol administration after haemodialysis on parathyroid function. J Am Soc Nephrol 1992, 3(3): 700.","journal-title":"Nephron"},{"issue":"38","key":"ref_227","first-page":"43","article-title":"Effects ofcalcitriol and non-calcaemic vitamin D analogues on secondary hyperparathyroidism","volume":"42","author":"Slatopolsky, E.; Berkoben, M.; Kelber, J.; Brown, A.; Delmez, J.","year":"1992","unstructured":"Kwan, J.T.C., Almond, M.K., Beer, J. & Cunningham, J. Evidence for tolerance to pulsed oral calcitriol in haemodialysis patients. J Am Soc Nephrol 1992, 3(3): 697.","journal-title":"Kidney Int"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000185718","article-title":"Disappearance of aluminic bone disease in long term asymptomatic dialysis population restricting Al (OH)3 intake: Emergence of an idiopathic adynamic bone disease not related to aluminium","volume":"53","author":"Moriniere, P.; Cohen-Solal, M.; Belbrick, S.","year":"1989","unstructured":"Varghese, Z., Moorhead, J.F. & Farrington, K. Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron 1992, 60: 286-291.","journal-title":"Nephron"},{"issue":"38","key":"ref_229","first-page":"62","article-title":"Risk of adynamic bone disease in dialysed patients","volume":"42","author":"Malluche, H.H.; Monier-Faugere, M.-C.","year":"1992","unstructured":"Slatopolsky, E., Berkoben, M., Kelber, J., Brown, A. & Delmez, J. Effects ofcalcitriol and non-calcaemic vitamin D analogues on secondary hyperparathyroidism. Kidney Int 1992, 42 (Suppl. 38): S43-S49.","journal-title":"Kidney Int"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/8756-3282(92)90354-Y","article-title":"Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?","volume":"13","author":"Cohen Solal, M.E.; Sebert, J.L.; Boudailliez, B.","year":"1992","unstructured":"Moriniere, P., Cohen-Solal, M., Belbrick, S. et al. Disappearance of aluminic bone disease in long term asymptomatic dialysis population restricting Al (OH)3 intake: Emergence of an idiopathic adynamic bone disease not related to aluminium. Nephron 1989, 53: 93-101.","journal-title":"Bone"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ki.1992.318","article-title":"Adequacy of dialysis: A critical analysis","volume":"42","author":"Vanholder, R.C.; Ringoir, S.M.","year":"1992","unstructured":"Malluche, H.H. & Monier-Faugere, M.-C. Risk of adynamic bone disease in dialysed patients. Kidney Int 1992, 42(Suppl. 38): S62-S67.","journal-title":"Kidney Int"},{"key":"ref_232","first-page":"81","article-title":"The genesis ofthe square metre-hour hypothesis","volume":"17","author":"Babb, A.L.; Popovich, R.P.; Christopher, T.G.; Scribner, B.H.","year":"1971","unstructured":"Cohen Solal, M.E., Sebert, J.L., Boudailliez, B. et al. Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment? Bone 1992, 13: 1-5.","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"38","key":"ref_233","first-page":"16","article-title":"The dose of hemodialysis according to dialysis prescription in Europe and the United States","volume":"42","author":"Held, P.J.; Blagg, C.R.; Liska, D.W.; Port, P.K.; Hakim, R.; Levin, N.","year":"1992","unstructured":"Vanholder, R.C. & Ringoir, S.M. Adequacy of dialysis: A critical analysis. Kidney Int 1992, 42: 540-558."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.1991.03460070053041","article-title":"Mortality and duration of hemodialysis treatment","volume":"265","author":"Held, P.J.; Levin, N.W.; Bovbjerg, R.R.; Pauly, M.V.; Diamond, L.H.","year":"1991","unstructured":"Babb, A.L., Popovich, R.P., Christopher, T.G. & Scribner, B.H. The genesis ofthe square metre-hour hypothesis. Trans Am Soc Artif Intern Organs 1971, 17: 81-91.","journal-title":"JAMA"},{"key":"ref_235","first-page":"367","article-title":"Long-term hemodialysis-implications of the Dialysis Index","volume":"24","author":"Raja, R.; Kramer, M.; Rosenbaum, J.","year":"1978","unstructured":"Held, P.J., Blagg, C.R., Liska, D.W., Port, P.K., Hakim, R. & Levin, N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 1992, 42(Suppl 38): S16-S21.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ndt\/5.5.347","article-title":"Urea kinetics and clinical evaluation of the haemodialysis patient","volume":"5","author":"Buur, T.; Timpka, T.; Lundberg, M.","year":"1990","unstructured":"Held, P.J., Levin, N.W., Bovbjerg, R.R., Pauly, M.V. & Diamond, L.H. Mortality and duration of hemodialysis treatment. JAMA 1991, 265: 871-875.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000182627","article-title":"Mortality risks in patients treated by chronic hemodialysis","volume":"31","author":"Degoulet, P.; Legrain, M.; Reach, I.","year":"1982","unstructured":"Raja, R., Kramer, M. & Rosenbaum, J. Long-term hemodialysis-implications of the Dialysis Index. Trans Am Soc Artif Intern Organs 1978, 24: 367-373.","journal-title":"Nephron"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in haemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie, E.G.; Lew, N.L.","year":"1990","unstructured":"Buur, T., Timpka, T. & Lundberg, M. Urea kinetics and clinical evaluation of the haemodialysis patient. Nephrol Dial Transplant 1990, 5: 347-351.","journal-title":"Am J Kidney Dis"},{"issue":"38","key":"ref_239","first-page":"22","article-title":"Race and diabetes as death predictors in haemodialysis patients","volume":"42","author":"Lowrie, E.G.; Lew, N.L.; Huang, W.H.","year":"1992","unstructured":"Degoulet, P., Legrain, M., Reach, I. et al. Mortality risks in patients treated by chronic hemodialysis. Nephron 1982, 31: 103-110.","journal-title":"Kidney Int"},{"issue":"30","key":"ref_240","first-page":"1286","article-title":"Assessment of protein calorie malnutrition","volume":"1984","author":"Haider, M.; Haider, S.Q.","unstructured":"Lowrie, E.G. & Lew, N.L. Death risk in haemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15: 458-482.","journal-title":"Clin Chem"},{"key":"ref_241","first-page":"1434","article-title":"Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet","volume":"2","author":"Phillips, A.; Shaper, G.; Whincup, P.H.","year":"1989","unstructured":"Lowrie, E.G., Lew, N.L. & Huang, W.H. Race and diabetes as death predictors in haemodialysis patients. Kidney Int 1992, 42(Suppl. 38): S22-S31."},{"issue":"6","key":"ref_242","first-page":"303","article-title":"Which mathematical model to study uremic toxicity? National Cooperative Dialysis Study","volume":"17","author":"Sargent, J.A.; Lowrie, E.G.","year":"1992","unstructured":"Haider, M. & Haider, S.Q. Assessment of protein calorie malnutrition. Clin Chem 1984, 30: 1286-1299.","journal-title":"Clin Nephrol"},{"issue":"13","key":"ref_243","first-page":"101","article-title":"G. Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study","volume":"23","author":"Laird, N.M.; Berkey, C.S.; Lowrie, E.","year":"1983","unstructured":"Phillips, A., Shaper, G. & Whincup, P.H. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989, 2: 1434-1436.","journal-title":"Kidney Int"},{"issue":"28","key":"ref_244","first-page":"526","article-title":"A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)","volume":"1985","author":"Gotch, F.A.; Sargent, J.A.","unstructured":"Sargent, J.A. & Lowrie, E.G. Which mathematical model to study uremic toxicity? National Cooperative Dialysis Study. Clin Nephrol 1992, 17(6): 303-314.","journal-title":"Kidney Int"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0272-6386(89)80021-6","article-title":"A hypothesis: The protein catabolic rate is dependent on the type and amount of treatment in dialysed uremic patients","volume":"13","author":"Lindsay, R.M.; Spanner, E.","year":"1989","unstructured":"Laird, N.M., Berkey, C.S. & Lowrie, E.G. Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 1983, 23 (Suppl. 13): S101 -S106.","journal-title":"Am J Kidney Dis"},{"issue":"38","key":"ref_246","first-page":"32","article-title":"Which comes first, Kt\/V or PCR - chicken or egg?","volume":"42","author":"Lindsay, R.M.; Spanner, E.; Heidenheim, P.","year":"1992","unstructured":"Gotch, F.A. & Sargent, J.A. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985, 28: 526-534.","journal-title":"Kidney Int"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0272-6386(12)80477-X","article-title":"Quantitating hemodialysis: a comparison of three kinetic models","volume":"17","author":"Flanigan, M.J.; Fangman, J.; Lim, V.S.","year":"1991","unstructured":"Lindsay, R.M. & Spanner, E. A hypothesis: The protein catabolic rate is dependent on the type and amount of treatment in dialysed uremic patients. Am J Kidney Dis 1989, 13: 382-389.","journal-title":"Am J Kidney Dis"},{"key":"ref_248","first-page":"364","article-title":"Various methods for calculation of Kt\/V: a clinical comparison","volume":"36","author":"Ijelu, G.; Corona, M.; Raja, R.M.","year":"1990","unstructured":"Lindsay, R.M., Spanner, E., Heidenheim, P. et al. Which comes first, Kt\/V or PCR - chicken or egg? Kidney Int 1992, 42(Suppl 38): S32-S36.","journal-title":"ASAIO Trans"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0272-6386(12)80590-7","article-title":"Percent reduction in blood urea concentration during dialysis estimates Kt\/V in a simple and accurate way","volume":"15","author":"Basile, C.; Casino, F.; Lopez, T.","year":"1990","unstructured":"Flanigan, M.J., Fangman, J. & Lim, V.S. Quantitating hemodialysis: a comparison of three kinetic models. Am J Kidney Dis 1991, 17: 295-302.","journal-title":"Am J Kidney Dis"},{"issue":"33","key":"ref_250","first-page":"227","article-title":"A reappraisal of the National Dialysis Cooperative Study","volume":"1988","author":"Keshaviah, P.R.; Collins, A.J.","unstructured":"Ijelu, G., Corona, M. & Raja, R.M. Various methods for calculation of Kt\/V: a clinical comparison. ASAIO Trans 1990, 36: M364-M366.","journal-title":"(NCDS) (Abstract). Kidney Int"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/ki.1992.191","article-title":"Survival as an index of adequacy of dialysis","volume":"41","author":"Charra, B.; Calemard, E.; Ruffet, M.","year":"1992","unstructured":"Basile, C., Casino, F. & Lopez, T. Percent reduction in blood urea concentration during dialysis estimates Kt\/V in a simple and accurate way. Am J Kidney Dis 1990, 15: 40-45.","journal-title":"Kidney Int"},{"issue":"34","key":"ref_252","first-page":"1","article-title":"Are there limitations to shortening dialysis treatment?","volume":"1988","author":"Collins, A.J.; Keshaviah, P.R.","unstructured":"Keshaviah, P.R. & Collins, A.J. A reappraisal of the National Dialysis Cooperative Study (NCDS) (Abstract). Kidney Int 1988, 33: 227.","journal-title":"ASAIO Trans"},{"issue":"34","key":"ref_253","first-page":"817","article-title":"Causes, kinetics, and clinical implications of post-haemodialysis urea rebound","volume":"1988","author":"Pedrini, L.A.; Zereik, S.; Rasmy, S.","unstructured":"Charra, B., Calemard, E., Ruffet, M. et al. Survival as an index of adequacy of dialysis. Kidney Int 1992, 41: 1286-1291.","journal-title":"Kidney Int"},{"issue":"3","key":"ref_254","first-page":"398","article-title":"Underdialysis caused by reliance on single-pool urea kinetic modelling","volume":"3","author":"Tattersall, J.; Farrington, K.; Aldridge, C.; Greenwood, R.N.","year":"1992","unstructured":"Collins, A.J. & Keshaviah, P.R. Are there limitations to shortening dialysis treatment? ASAIO Trans 1988, 34: 1-5.","journal-title":"J Am Soc Nephrol"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ki.1991.84","article-title":"Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients","volume":"39","author":"Blake, P.G.; Sombolos, K.; Abraham, G.","year":"1991","unstructured":"Pedrini, L.A., Zereik, S. & Rasmy, S. Causes, kinetics, and clinical implications of post-haemodialysis urea rebound. Kidney Int 1988, 34: 817-821.","journal-title":"Kidney Int"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ki.1992.305","article-title":"A longitudinal, five year survey of urea kinetic parameters in CAPD patients","volume":"42","author":"Ringoir, S.","year":"1992","unstructured":"Tattersall, J., Farrington, K., Aldridge, C. & Greenwood, R.N. Underdialysis caused by reliance on single-pool urea kinetic modelling. J Am Soc Nephrol 1992, 3(3): 398.","journal-title":"Kidney Int"},{"issue":"3","key":"ref_257","first-page":"420","article-title":"Urea kinetic modelling and underdialysis in CAPD patients","volume":"3","author":"Tattersall, J.E.; Doyle, S.; Greenwood, R.N.; Farrington, K.","year":"1992","unstructured":"Blake, P.G., Sombolos, K., Abraham, G. et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991, 39: 700-706.","journal-title":"J Am Soc Nephrol"},{"key":"ref_258","first-page":"181","article-title":"Urea kinetic analysis and clinical outcome on CAPD. A 5 year longitudinal study","volume":"6","author":"Teehan, B.P.; Schleifer, C.R.; Brown, J.M.; Sigler, C.R.; Raimondo, J.","year":"1990","unstructured":"Ringoir, S. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992, 42: 426-432.","journal-title":"Adv Perit Dial"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/089686088900900405","article-title":"The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis","volume":"9","author":"Keshaviah, P.R.; Nolph, K.D.; Van Stone, J.C.","year":"1989","unstructured":"Tattersall, J.E., Doyle, S., Greenwood, R.N. & Farrington, K. Urea kinetic modelling and underdialysis in CAPD patients. J Am Soc Nephrol 1992, 3(3): 420.","journal-title":"Perit Dial Int"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0272-6386(12)80954-1","article-title":"Hypertension is not adequately controlled in hemodialysis patients","volume":"19","author":"Cheigh, J.S.; Melite, C.; Sullivan, J.F.; Rubin, A.L.; Stenzel, K.H.","year":"1992","unstructured":"Teehan, B.P., Schleifer, C.R., Brown, J.M., Sigler, C.R. & Raimondo, J. Urea kinetic analysis and clinical outcome on CAPD. A 5 year longitudinal study. Adv Perit Dial 1990, 6: 181-185.","journal-title":"Am J Kidney Dis"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(92)90687-T","article-title":"Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis","volume":"69","author":"Huting, J.; Schutterle, G.","year":"1992","unstructured":"Keshaviah, P.R., Nolph, K.D. & Van Stone, J.C. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Perit Dial Int 1989, 9: 257-260.","journal-title":"Am J Cardiol"},{"key":"ref_262","first-page":"291","article-title":"Carpal-tunnel syndrome, shoulder pain and amyloid deposits","volume-title":"long-term hemodialysis patients. Proc Eur Dial Transplant Assoc","volume":"21","author":"Charra, B.; Calemard, E.; Uzan, M.; Terrat, J.C.; Vannel, T.; Laurent, G.","year":"1984","unstructured":"Cheigh, J.S., Melite, C., Sullivan, J.F., Rubin, A.L. & Stenzel, K.H. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992, 19: 453-459."},{"issue":"129","key":"ref_263","first-page":"701","article-title":"A new form of amyloid protein associated with chronic hemodialysis was identified as B2-microglobulin","volume":"1985","author":"Gejyo, F.; Yamada, T.; Odani, S.","unstructured":"Huting, J. & Schutterle, G. Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol 1992, 69: 123-127.","journal-title":"Biochem Biophys Res Comm"},{"key":"ref_264","first-page":"17","article-title":"Dialysis-related amyloidosis during peritoneal dialysis","volume":"36","author":"Brown, E.; Soldano, L.; Hendler, E.","year":"1990","unstructured":"Charra, B., Calemard, E., Uzan, M., Terrat, J.C., Vannel, T. & Laurent, G. Carpal-tunnel syndrome, shoulder pain and amyloid deposits in long-term hemodialysis patients. Proc Eur Dial Transplant Assoc 1984, 21: 291-295.","journal-title":"ASAIO Trans"},{"key":"ref_265","first-page":"701","article-title":"Destructive spondyloarthropathy in dialysis patients: an overview","volume":"129","author":"Bindi, P.; Chanard, J.","year":"1990","unstructured":"Gejyo, F., Yamada, T., Odani, S. et al. A new form of amyloid protein associated with chronic hemodialysis was identified as B2-microglobulin. Biochem Biophys Res Comm 1985, 129: 701-706.","journal-title":"Nephron"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780270402","article-title":"Destructive spondyloarthropathy in dialysis patients. A new syndrome","volume":"27","author":"Kuntz, D.; Naveau, B.; Bardin, T.; Drueke, T.; Treves, R.; Dryll, A.","year":"1984","unstructured":"Brown, E., Soldano, L. & Hendler, E. Dialysis-related amyloidosis during peritoneal dialysis. ASAIO Trans 1990, 36: 17-20.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref_267","first-page":"117","article-title":"Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome","volume":"1988","author":"Charra, B.; Calemard, E.; Laurent, G.","unstructured":"Bindi, P. & Chanard, J. Destructive spondyloarthropathy in dialysis patients: an overview. Nephron 1990, 129: 701-706.","journal-title":"Blood Purif"},{"issue":"17","key":"ref_268","first-page":"401","article-title":"Dialysis amyloidosis","volume":"1988","author":"Van Ypersele de Strihou, C.; Honhon, B.; Vandenbrouke, J.M.; Huaux, J.P.; Noel, H.; Maldague, B.","unstructured":"Kuntz, D., Naveau, B., Bardin, T., Drueke, T., Treves, R. & Dryll, A. Destructive spondyloarthropathy in dialysis patients. A new syndrome. Arthritis Rheum 1984, 27: 369-375.","journal-title":"Adv Nephrol"},{"key":"ref_269","first-page":"\"1012","article-title":"Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis","volume":"39","author":"van Ypersele de Strihou, C.; Jadoul, M.; Malghem, J.; Maldague, B.; Jamart, J.","year":"1991","unstructured":"Charra, B., Calemard, E. & Laurent, G. Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome. Blood Purif 1988, 6: 117-124.","journal-title":"Kidney Int; Gastrointestinal complications ofdialysis related amyloidosis"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ki.1990.16","article-title":"Influence of uraemia and hemodialysis on circulating interleukin-l and tumor necrosis factor","volume":"37","author":"Herbelin, A.; Thu Nguyen, A.; Zingraff, J.; Urena, P.; Descamps-Latscha, B.","year":"1990","unstructured":"Van Ypersele de Strihou, C., Honhon, B., Vandenbrouke, J.M., Huaux, J.P., Noel, H. & Maldague, B. Dialysis amyloidosis. Adv Nephrol 1988, 17: 401-422.","journal-title":"Kidney Int"},{"issue":"28","key":"ref_271","first-page":"158","article-title":"Hemodialysis membrane induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood","volume":"1985","author":"Thu Nguyen, A.; Lethias, C.; Zingraff, J.; Herbelin, A.; Naret, C.; Descamps-Latscha, B.","unstructured":"van Ypersele de Strihou, C., Jadoul, M., Malghem, J., Maldague, B. & Jamart, J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991, 39: 1012-1019. Maher, E.R., Hamilton Dutoit, S., Baillod, R.A., Sweny, P. & Moorhead, J.F. Gastrointestinal complications ofdialysis related amyloidosis. Br Med J 1988, 297: 265-266.","journal-title":"Kidney Int"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM198410043111403","article-title":"Complement activation and hypersensitivity reactions to dialysis membranes","volume":"311","year":"1984","unstructured":"Herbelin, A., Thu Nguyen, A., Zingraff, J., Urena, P. & Descamps-Latscha, B. Influence of uraemia and hemodialysis on circulating interleukin-l and tumor necrosis factor. Kidney Int 1990, 37: 116-125.","journal-title":"N Engl J Med"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ki.1990.298","article-title":"Effects of dialysis membranes on beta 2-microglobulin production and cellular expression","volume":"38","author":"Zaoui, P.M.; Stone, W.J.; Hakim, R.M.","year":"1990","unstructured":"Thu Nguyen, A., Lethias, C., Zingraff, J., Herbelin, A., Naret, C. & Descamps-Latscha, B. Hemodialysis membrane induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985, 28: 158-167.","journal-title":"Kidney Int"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000185232","article-title":"Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful?","volume":"51","author":"Floege, J.; Granolleras, C.; Merscher, S.","year":"1989","unstructured":"Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984, 311: 878-882.","journal-title":"Nephron"},{"key":"ref_275","first-page":"22","article-title":"Determinants of Beta 2-microglobulin concentration: possible relation to membrane biocompatibility","volume":"2","author":"Bommer, J.; Seelig, P.; Seelig, R.","year":"1987","unstructured":"Zaoui, P.M., Stone, W.J. & Hakim, R.M. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression. Kidney Int 1990, 38: 962-968.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_276","first-page":"14","article-title":"Enhancement ofin vitro human interleukinproduction by sodium acetate","volume":"1","author":"Bingel, M.; Lonnemann, G.; Koch, K.M.; Shaldon, S.","year":"1987","unstructured":"Floege, J., Granolleras, C., Merscher, S. et al. Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful? Nephron 1989, 51: 6-12.","journal-title":"Lancet"},{"issue":"33","key":"ref_277","first-page":"29","article-title":"Detection of endotoxin-like interleukin-l induction during in vitro dialysis","volume":"1988","author":"Lonnemann, G.; Bingel, M.; Floege, J.; Koch, K.M.; Shaldon, S.; Dinarello, C.A.","unstructured":"Bommer, J., Seelig, P., Seelig, R. et al. Determinants of Beta 2-microglobulin concentration: possible relation to membrane biocompatibility. Nephrol Dial Transplant 1987, 2: 22-25.","journal-title":"Kidney Int"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/039139888901200805","article-title":"Factors affecting beta 2-microglobulin plasma concentration during hemodialysis","volume":"12","author":"Martin Malo, A.; Mallol, J.; Castillo, D.","year":"1989","unstructured":", 11: 459-464.","journal-title":"Int J Artif Organs"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0272-6386(89)80022-8","article-title":"Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse","volume":"13","author":"DiRaimondo, C.R.; Pollak, V.E.","year":"1989","unstructured":", 4: 549-554.","journal-title":"Am J Kidney Dis"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/039139888901200605","article-title":"Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures","volume":"12","author":"Goldman, M.; Lagmiche, M.; Dhaene, M.; Amraoui, Z.; Thayse, C.; Vanherweghem, J.L.","year":"1989","unstructured":"Bingel, M., Lonnemann, G., Koch, K.M. & Shaldon, S. Enhancement ofin vitro human interleukinproduction by sodium acetate. Lancet 1987, 1: 14-16.","journal-title":"Int J Artif Organs"},{"issue":"3","key":"ref_281","first-page":"784","article-title":"Beta-2 kinetics during hemofiltration","volume":"1988","author":"Floege, J.; Wilks, M.; Shaldon, S.; Koch, K.M.; Smeby, L.C.","unstructured":"Lonnemann, G., Bingel, M., Floege, J., Koch, K.M., Shaldon, S. & Dinarello, C.A. Detection of endotoxin-like interleukin-l induction during in vitro dialysis. Kidney Int 1988, 33: 29-35.","journal-title":"Nephrol Dial Transplant"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/089686088900900419","article-title":"Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD)","volume":"9","author":"Colombi, A.; Wegmann, W.","year":"1989","unstructured":"Martin Malo, A., Mallol, J., Castillo, D. et al. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis. Int J Artif Organs 1989, 12: 509-514.","journal-title":"Perit Dial Int"},{"key":"ref_283","first-page":"194","article-title":"Effect ofrenal transplantation on the radiological signs ofdialysis amyloid osteoarthropathy","volume":"32","author":"Jadoul, M.; Malghem, J.; Pirson, Y.; Maldague, B.; van Ypersele de Strihou, C.","year":"1989","unstructured":"DiRaimondo, C.R. & Pollak, V.E. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse. Am J Kidney Dis 1989, 13: 390-395.","journal-title":"Clin Nephrol"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/anr.1780320619","article-title":"Rheumatic syndromes and beta 2-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis","volume":"32","author":"Corelis, F.; Bardin, T.; Faller, B.","year":"1989","unstructured":"Goldman, M., Lagmiche, M., Dhaene, M., Amraoui, Z., Thayse, C. & Vanherweghem, J.L. Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures. Int J Artif Organs 1989, 12: 373-378.","journal-title":"Arthritis Rheum"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000185676","article-title":"Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis","volume":"52","author":"Sethi, D.; Murphy, C.M.; Brown, E.A.; Muller, B.R.; Gower, P.E.","year":"1989","unstructured":"Floege, J., Wilks, M., Shaldon, S., Koch, K.M. & Smeby, L.C. Beta-2 kinetics during hemofiltration. Nephrol Dial Transplant 1988, 3: 784-789.","journal-title":"Nephron"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0272-6386(89)80119-2","article-title":"Beta 2microglobulin levels in patients with renal unsufficiency","volume":"13","author":"Acchiardo, S.; Kraus, A.P.J.; Jennings, B.R.","year":"1989","unstructured":"Colombi, A. & Wegmann, W. Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989, 9: 321-34.","journal-title":"Am J Kidney Dis"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ndt\/5.7.513","article-title":"Kinetic and clinical studies of beta 2microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer","volume":"5","author":"Mistry, C.D.; O'Donoghue, D.J.; Nelson, S.; Gokal, R.; Ballardie, F.W.","year":"1990","unstructured":"Jadoul, M., Malghem, J., Pirson, Y., Maldague, B. & van Ypersele de Strihou, C. Effect ofrenal transplantation on the radiological signs ofdialysis amyloid osteoarthropathy. Clin Nephrol 1989, 32: 194-197.","journal-title":"Nephrol Dial Transplant"},{"issue":"44","key":"ref_288","first-page":"163","article-title":"CAPD is a second class treatment","volume":"1985","author":"Shaldon, S.; Koch, K.M.; Quellhorst, E.; Lonnemann, G.; Dinarello, C.A.","unstructured":"Corelis, F., Bardin, T., Faller, B. et al. Rheumatic syndromes and beta 2-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 1989, 32: 785-788.","journal-title":"Contrib Nephrol"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.245","article-title":"Lysine-specific cleavage of Beta-2 microglobulin in amyloid deposits associated with haemodialysis","volume":"36","author":"Linke, R.P.; Hampl, H.; Lobeck, H.","year":"1990","unstructured":"Sethi, D., Murphy, C.M., Brown, E.A., Muller, B.R. & Gower, P.E. Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis. Nephron 1989, 52: 352-355.","journal-title":"Kidney Int"},{"issue":"30","key":"ref_290","first-page":"142","article-title":"Detection of a novel beta-2 microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition","volume":"1988","author":"Ogawa, H.; Saito, A.; Oda, O.; Nakajima, M.; Chung, T.G.","unstructured":"Acchiardo, S., Kraus, A.P.J. & Jennings, B.R. Beta 2microglobulin levels in patients with renal unsufficiency. Am J Kidney Dis 1989, 13: 70-74.","journal-title":"Clin Nephrol"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1525-139X.1990.tb00032.x","article-title":"New insights into the pathogenesis of haemodialysis-associated amyloidosis","volume":"3","author":"Argiles, A.; Mourad, G.; Atkins, R.C.; Mion, C.H.","year":"1990","unstructured":"Mistry, C.D., O'Donoghue, D.J., Nelson, S., Gokal, R. & Ballardie, F.W. Kinetic and clinical studies of beta 2microglobulin in continuous ambulatory peritoneal dialysis: influence of renal and enhanced peritoneal clearances using glucose polymer. Nephrol Dial Transplant 1990, 5: 513-519.","journal-title":"Sem Dial"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ki.1992.207","article-title":"Dialysis-related amyloidosis","volume":"41","author":"Koch, K.M.","year":"1992","unstructured":"Shaldon, S., Koch, K.M., Quellhorst, E., Lonnemann, G. & Dinarello, C.A. CAPD is a second class treatment. Contrib Nephrol 1985, 44: 163-172.","journal-title":"Kidney Int"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80283-6","article-title":"Can the nephrologist prevent dialysis-related amyloidosis?","volume":"18","author":"Zingraff, J.; Drueke, T.","year":"1991","unstructured":"Linke, R.P., Hampl, H., Lobeck, H. et al. Lysine-specific cleavage of Beta-2 microglobulin in amyloid deposits associated with haemodialysis. Kidney Int 1990, 36: 675-681.","journal-title":"Am J Kidney Dis"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(91)90478-8","article-title":"Imaging of haemodialysis-associated amyloidosis wih '23I-serum amyloid P component","volume":"338","author":"Nelson, S.R.; Hawkins, P.N.; Richardson, S.","year":"1991","unstructured":"Ogawa, H., Saito, A., Oda, O., Nakajima, M. & Chung, T.G. Detection of a novel beta-2 microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition. Clin Nephrol 1988, 30: 142-152.","journal-title":"Lancet"},{"key":"ref_295","first-page":"\"1169","article-title":"Imaging of dialysis-related amyloid (AB-amyloid) deposits with 31Ibeta 2-microglobulin","volume":"38","author":"Hawkins, P. N., Lavender, J. P., Myers, M. J. & Pepys, M. B.","year":"1990","unstructured":"Argiles, A., Mourad, G., Atkins, R.C. & Mion, C.H. New insights into the pathogenesis of haemodialysis-associated amyloidosis. Sem Dial 1990, 3: 149-152.","journal-title":"Lancet; Diagnostic imaging of amyloid: biological targeting by circulating human serum amyloid P component"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM199209173271202","article-title":"For the UNOS Scientifici Renal Transplant Registry. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors","volume":"327","author":"Takemoto, S.; Terasaki, P.I.; Cecka, M.; Cho, Y.W.; Gjertson, D.W.","year":"1992","unstructured":"Koch, K.M., Dialysis-related amyloidosis. Kidney Int 1992, 41: 1416-1429.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref_297","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199201000-00011","article-title":"Analysis of the UNOs scientific renal transplant registry at three years early events affecting transplant success","volume":"53","author":"Cecka, J.M.; Cho, Y.W.; Terasaki, P.I.","year":"1992","unstructured":"Zingraff, J. & Drueke, T. Can the nephrologist prevent dialysis-related amyloidosis? Am J Kidney Dis 1991, 18: 1-11.","journal-title":"Transplantation"},{"key":"ref_298","first-page":"\"461","article-title":"Survival of DNA HLA-DR typed and matched cadaver kidney transplants","volume":"338","author":"First, M. R.","year":"1991","unstructured":"Nelson, S.R., Hawkins, P.N., Richardson, S. et al. Imaging of haemodialysis-associated amyloidosis wih '23I-serum amyloid P component. Lancet 1991, 338: 335-339.","journal-title":"Lancet; Renal transplantation for the nephrologist: new immunosuppressive drugs"},{"issue":"38","key":"ref_299","first-page":"182","article-title":"Molecular immunology and immunopharmacology of allograft rejection","volume":"42","author":"Strom, T.B.","year":"1992","unstructured":"Floege, J,. Burchert, W., Brandis, A. et al. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 31Ibeta 2-microglobulin. Kidney Int 1990, 38: 1169-1176. Hawkins, P.N., Lavender, J.P., Myers, M.J. & Pepys, M.B. Diagnostic imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988, 1: 1413-1418.","journal-title":"Kidney Int"},{"key":"ref_300","first-page":"25","article-title":"FK506: an immunosuppressant for the 1990's","volume":"337","author":"MacLeod, A.M.; Thomson, A.W.","year":"1991","unstructured":"Takemoto, S., Terasaki, P.I., Cecka, M., Cho, Y.W., Gjertson, D.W. For the UNOS Scientifici Renal Transplant Registry. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992, 327: 834-839.","journal-title":"Lancet"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007890-199108000-00001","article-title":"Preclinical evaluation of a new potent immunosuppressive agent, Rapamycin","volume":"52","author":"Kahan, B.D.; Chang, T.Y.; Sehgal, S.N.","year":"1991","unstructured":"Cecka, J.M., Cho, Y.W. & Terasaki, P.I. Analysis of the UNOs scientific renal transplant registry at three years early events affecting transplant success. Transplantation 1992, 53(1): 59-64.","journal-title":"Transplantation"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00007890-199101000-00003","article-title":"RS61443 - a new, potent immunosuppressive agent","volume":"51","author":"true","year":"1991","unstructured":"Opelz, G,. Mytilineos, J. & Scherer, S. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991, 338: 461-463. First, M.R. Renal transplantation for the nephrologist: new immunosuppressive drugs. Am J Kidney Dis 1992, 19(1): 3-9.","journal-title":"Transplantation"},{"key":"ref_303","article-title":"A short-term controlled trial of cyclosporin A","volume-title":"Is A nephropathy. Transplant Proc","volume":"\"(Suppl\" # \"297.\"","author":"Lai, K.N.; Mac-Moune Lai, F.; Vallance-Owen, J.","year":"1988","unstructured":"Strom, T.B. Molecular immunology and immunopharmacology of allograft rejection. Kidney Int 1992, 42(S38): 182-187."},{"key":"ref_304","first-page":"17","article-title":"15-Deoxyspergualin - A novel immunosuppressant: experimental studies and clinical trials","volume":"7","author":"Suzuki, S.; Amemiya, H.","year":"1990","unstructured":"MacLeod, A.M. & Thomson, A.W. FK506: an immunosuppressant for the 1990's. Lancet 1991, 337: 25-27.","journal-title":"Transplant Immunol Lett"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Kohler, G.; Milstein, C.","year":"1975","unstructured":"Kahan, B.D., Chang, T.Y. & Sehgal, S.N. Preclinical evaluation of a new potent immunosuppressive agent, Rapamycin. Transplantation 1991, 52: 185-191.","journal-title":"Nature"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/349293a0","article-title":"Man-made antibodies","volume":"349","author":"Winter, G.; Milstein, C.","year":"1991","unstructured":"Platz, K.P., Sollinger, H.W,. Hullett, D.A. et al. RS61443 - a new, potent immunosuppressive agent. Transplantation 1991, 51: 27-31.","journal-title":"Nature"},{"key":"ref_307","first-page":"3","article-title":"A chimeric CD7 monoclonal antibody (SDZ CHM 380) for organ transplanation","volume":"7","author":"Amlot, P.L.; Cataigne, T.P.; Sweny, P.","year":"1991","unstructured":"Lai, K.N., Mac-Moune Lai, F. & Vallance-Owen, J. A short-term controlled trial of cyclosporin A in Is A nephropathy. Transplant Proc 1988, 20 (Suppl 4) 297.","journal-title":"Transplantation and Immunology Letter"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007890-199110000-00001","article-title":"CD4 monoclonal antibodies in organ transplantation. A review ofprogress","volume":"52","author":"Sablinski, T.; Hancock, W.W.; Tilney, N.L.; KupiecWeglinski, J.W.","year":"1991","unstructured":"Suzuki, S. & Amemiya, H. 15-Deoxyspergualin - A novel immunosuppressant: experimental studies and clinical trials. Transplant Immunol Lett 1990, 7: 17-19.","journal-title":"Transplantation"},{"key":"ref_309","first-page":"820","article-title":"Immunosuppression with anti-ICAM-I (CD54) mAb in renal allograft recipients (Abstract)","volume":"2","author":"Tolkoff-Rubin, N.; Rothlein, R.; Scharschmidt, L.","year":"1991","unstructured":"Kohler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256: 495-497.","journal-title":"J Am Soc Nephrol"},{"issue":"8796","key":"ref_310","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0140-6736(92)91897-H","article-title":"Induction of thrombosis within renal grafts by high dose prophylactic OKT3","volume":"339","author":"Abramowicz, D.; Pradier, O.; Marchant, A.","year":"1992","unstructured":"Winter, G. & Milstein, C. Man-made antibodies. Nature 1991, 349: 293-299.","journal-title":"Lancet"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM199004263221702","article-title":"Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts","volume":"322","author":"Soulillou, J.P.; Cantarovich, D.; Le Mauff, B.","year":"1990","unstructured":"Amlot, P.L., Cataigne, T.P. & Sweny, P. A chimeric CD7 monoclonal antibody (SDZ CHM 380) for organ transplanation. Transplantation and Immunology Letter 1991, 7: 3.","journal-title":"N Engl J Med"},{"key":"ref_312","first-page":"299","article-title":"Ideal immunosuppression after renal transplantation: are steroids needed?","volume-title":"International Year Book of Nephrology","author":"Mathew, T.H.","year":"1992","unstructured":"Sablinski, T., Hancock, W.W., Tilney, N.L. & KupiecWeglinski, J.W. CD4 monoclonal antibodies in organ transplantation. A review ofprogress. Transplantation 1991, 52: 579-589."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1432-2277.1990.tb01880.x","article-title":"Conversion ofstable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled trial","volume":"3","author":"Sweny, P.; Lui, S.F.; Scoble, J.E.; Varghese, Z.; Fernando, O.N.; Moorhead, J.F.","year":"1990","unstructured":"Tolkoff-Rubin, N., Rothlein, R., Scharschmidt, L. et al. Immunosuppression with anti-ICAM-I (CD54) mAb in renal allograft recipients (Abstract). J Am Soc Nephrol 1991, 2: 820.","journal-title":"Transpl Int"},{"key":"ref_314","first-page":"176","article-title":"treatment of steroid-resistant renal allograft rejection","volume":"3","author":"Thistlewaite, J.R.; Gaber, A.O.; Haag, B.W.","unstructured":"Abramowicz, D., Pradier, O., Marchant, A. et al. Induction of thrombosis within renal grafts by high dose prophylactic OKT3. Lancet 1992, 339(8796): 777-778.","journal-title":"et al"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00007890-198903000-00011","article-title":"Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft - a pilot study","volume":"47","author":"Cantarovich, D.; Le Mauff, B.; Hourmant, M.","year":"1989","unstructured":"Soulillou, J.P., Cantarovich, D., Le Mauff, B. et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990, 322: 1175-1182.","journal-title":"Transplantation"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ndt\/7.7.636","article-title":"Lipid and lipoprotein (a) concentrations in renal transplant patients","volume":"7","author":"Webb, A.T.; Plant, M.; Reaveley, D.A.","year":"1992","unstructured":"Mathew, T.H. Ideal immunosuppression after renal transplantation: are steroids needed? In: Andreucci, V.E. & Fine, L.G. (eds) International Year Book of Nephrology. Springer Verlag, London, 1992, pp. 299-312.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"ref_317","volume":"25","author":"Proceedings of the 4th Alexis Carrel Conference. Sweden 1992. Transplant Proceedings","year":"1993","unstructured":"Sweny, P., Lui, S.F., Scoble, J.E., Varghese, Z., Fernando, O.N. & Moorhead, J.F. Conversion ofstable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled trial. Transpl Int 1990, 3: 19-22."}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/69\/813\/516\/50073004\/postgradmedj-69-516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/69\/813\/516\/50073004\/postgradmedj-69-516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:23:15Z","timestamp":1709868195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/69\/813\/516\/7062866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7,1]]},"references-count":317,"journal-issue":{"issue":"813","published-online":{"date-parts":[[1993,7,1]]},"published-print":{"date-parts":[[1993,7,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.69.813.516","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1993,7]]},"published":{"date-parts":[[1993,7,1]]}}}